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 Abstract 
Seasonal influenza is associated with significant morbidity and mortality among older 
adults, aged 65 and older. Since vaccination is the single most effective preventive 
measure against seasonal influenza, clinicians and senior citizen center administrators 
need a better understanding of the perceptions of older adults concerning the reason for 
poor influenza vaccine uptake. The purpose of this study was to identify perceived factors 
that may be associated with poor influenza vaccination uptake among older adults. The 
health belief model (HBM) guided the study. The research questions examined 
perceptions predicting the odds of influenza vaccination uptake among older adults. This 
quantitative cross-sectional study consisted of administration of a newly developed 33-
item questionnaire to a convenience sample of 147 older adult participants. A 2-week 
reliability test-retest on 50 participants indicated the instrument had moderate internal 
consistency (α ≥ 0.7). Paired-sample t tests were not significant (p > .05), indicating that 
participants provided reliable responses across time. Ordinal regression analysis indicated 
that all HBM constructs were significantly associated (susceptibility, barriers, benefits, 
cues to action, and self-efficacy p = .000; severity p = .002) with frequency of influenza 
disease and recency of influenza vaccine uptake within 1 year. The social change 
implications from this study may help to improve vaccination uptake among older adults 
by providing senior public health decision makers and direct care clinicians with 
informed knowledge on perceptions and barriers that may play a role in influenza 
vaccination decision-making among older adults.   
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Chapter 1: Introduction to the Study 
Introduction 
Seasonal influenza is a contagious airborne respiratory disease that spreads from 
person to person during episodes of coughing or sneezing or through contact with 
frequently handled infected surfaces (Centers for Disease Control and Prevention [CDC], 
2012-2013). A group of influenza viruses, Types A, B, and C, cause the influenza 
disease. These viruses continuously keep changing; every few decades, a new version of 
the influenza virus emerges in the human population, causing serious global outbreaks of 
disease associated with severe complications, hospitalizations, and death among older 
adults (CDC, 2012-2013). The influenza outbreaks can also contribute to social 
disruption and economic loss among the population.  
This study was conducted because the knowledge gained may help clinicians to 
better understand contributing factors associated with decreased influenza vaccine uptake 
among the elderly in order to identify strategies that improve influenza vaccine uptake 
among older adults. The social change implications in this study are to improve influenza 
vaccine uptake among older adults and to provide senior public health decision makers 
and direct care clinicians with informed knowledge of the benefits and limitations of 
influenza screening and immunization for the older adult population. Other major study 
sections included in this chapter are background, problem statement, purpose, research 
questions, theoretical framework, nature of the study, definition of terms, assumptions, 
scope and limitations, and the significance of the study. 
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Background of the Study 
A seasonal influenza outbreak usually occurs in the United States in late fall 
through early spring, causing severe illnesses and death, especially among the elderly and 
children (CDC, 2012). Although influenza affects all ages, older adults are particularly 
vulnerable because they often have chronic illnesses, which put them at a greater risk for 
influenza complications, including pneumonia (Molinari et al., 2007). Influenza and 
pneumonia is the seventh leading cause of death among the elderly (Centers for Medicare 
and Medicaid Services (CMS), 2011), and the annual rate of influenza-associated death 
among ages 65 and older is 45,321 deaths per 100,000 persons (United States Census 
Bureau, 2011).   
Individuals with chronic conditions, such as congestive heart failure, asthma, or 
diabetes, are particularly at risk for higher incidence, severity, and complications of 
influenza attack (CDC, 2013-2014). Although the U.S. government set a national goal of 
achieving a 90.0% annual immunization rate for persons over 65 (Healthy People, 2010), 
the national rate continues to be at a staggering low for this population (CDC, 2012). The 
burden of influenza related illnesses and death from these diseases is greater in Brooklyn 
and New York City, which is higher than the nation as a whole (CMS, 2011; SUNY 
Downstate Medical Center, 2010). A survey carried out among Brooklyn residents 
reported that influenza and pneumonia combined is the third leading cause of death 
(CMS, 2011) in Brooklyn (SUNY Downstate Medical Center, 2010). The influenza 
vaccine is the most effective in protecting individuals from influenza viruses and related 
complications (CDC, 2012). The report from the survey indicated that 46.2% of Brooklyn 
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residents over the age of 65 did not receive the annual influenza vaccine compared to 
those living in New York City (SUNY Downstate Medical Center, 2010). Three out of 
the 11 Brooklyn neighborhoods with a higher percentage of persons 50 to 65 years and 
older and never received the influenza vaccine were selected for this study. The three 
selected areas with a higher percentage of low influenza vaccine uptakes were Bedford 
Stuyvesant-Crown Heights, 62.7%, Canarsie-Flatlands, 72.3%, and East New York, 
69.8%. The pneumonia hospitalization rates per 100,000 for people age 65 in the three 
selected neighborhoods were Bedford Stuyvesant-Crown Heights, 160.0, Canarsie-
Flatlands, 100.3, and East New York, 181.4 (Healthcare Association of New York State; 
HANYS, and Structured Psychotherapy for Adolescents Responding to Chronic Stress; 
SPARCS. 2008). Influenza and pneumonia death rates for these areas in 2000 and 2007 
were Bedford Stuyvesant-Crown Heights, 29.0 and 36.6, Canarsie-Flatlands, 21.8 and 
16.5, and East New Yok, 30.0 and 31.6 (Equerry: Vital Statistics Mortality Data Sets, 
New York City Department of Health and Mental Hygiene; NYCDOHMH, 2009).  
There is a gap in knowledge among clinicians in how they handle the influenza 
epidemic among older adults. Due to this epidemic, there is an urgent need to evaluate 
the perception of the older adults concerning influenza vaccine uptake. Such evaluations 
may also help clinicians to identify appropriate strategies in reaching the older adult 
population who are at a greater risk for severe complications and death from influenza. 
There is an ongoing need for influenza vaccine planning for the older adult population. 
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Problem Statement 
CDC (2013, 2014) recommended the yearly influenza vaccine as one of the first 
and most important steps in protecting individuals against the seasonal influenza viruses. 
The seasonal influenza vaccine protects against the three influenza viruses to prevent 
unnecessary hospitalizations and premature deaths among older adults (CDC 2012, 
2013). Researchers have indicated that many older adults do not obtain the influenza 
vaccine despite the many publicized strategies used to promote the importance of 
immunization among this age group (Evans, Prout, Prior, Tapper-Jones, Butler, 2007; 
Ward & Draper, 2008). Few researchers have focused on identifying the perceptions and 
determinants of seasonal influenza vaccination among older adults (Kohlhammer, 
Schnoor, Schwartz, Raspe, & Schäfer, 2007; Nagata et al., 2013). Perception about health 
plays a critical role in disease consequences (Nagata et al., 2013). Few studies have 
addressed the underlying perception of emerging older adults as it relates to the threat of 
influenza and the importance of getting the annual influenza vaccine. In addition, 
clinician/patient communication is a contributing factor but has not been fully explored 
among this age group. In this study, the perceptions of older adults in receiving the 
influenza vaccine and clinician/patient communication about the seasonal influenza 
vaccine are examined. The key constructs of the health belief model (HBM) and 
sociodemographic factors guided the identification of reasons for poor uptake of the 
influenza vaccine among older adults in three areas in Brooklyn, New York where the 
vaccine uptake is low. 
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Purpose of the Study 
The purpose of this study was to identify perceived factors that may be associated 
with poor influenza vaccination uptake among older adults. Using a quantitative 
approach, I intended to identify older adults’ perception about the seasonal influenza 
vaccine. Increased uptake of the influenza vaccine can decrease influenza related 
complications and death among the older adults. 
Nature of the Study 
This was a quantitative descriptive study involving cross-sectional data from a 
group of respondents 65 years and older in the three selected senior citizen centers in 
Brooklyn, New York. The data collected were consistent with understanding the 
perceptions of older adults that contributed to poor uptake of the seasonal influenza 
vaccination. In addition, data collection identified whether clinician and patient 
communication were contributory factors for receiving the influenza vaccination. The 
independent variables for this study included the full HBM constructs: perceived 
susceptibility, perceived severity, perceived barriers, perceived benefits, perceived cues 
to action, perceived self-efficacy, and the mediating demographic factors related to poor 
uptake of influenza vaccine among older adults. The dependent variables are recency of 
influenza vaccine uptake (≤ 1 year) and frequency of influenza disease (number of 
infections within the last year). The covariates consisted of demographic factors such as 
gender, age, ethnicity, knowledge, income, employment status, and location and were 
used to measure with accuracy those variables that formed the basis for this research. 
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The sample included 147 participants. The study sample was selected from three 
senior centers that provide both clinical and recreational services. Thus, random sampling 
and availability of individual respondents were not feasible as planned. Instead, 
participants were selected as a convenience sample consisting of older adult clients who 
came into the center and agreed to participate in the study. Participants were interviewed 
and recorded until the required sample of 147 respondents was obtained.  
Research Questions and Hypotheses 
A new HBM scale, Health Belief Model Scale (HBMS) was created based on a 
review of past studies that used the HBM. The research questions and the hypotheses 
were based on the review of existing literature on seasonal influenza uptake among older 
adults and studies that previously used the HBM. To investigate the perceptions of older 
adults about the influenza vaccine uptake, the constructs of the HBM and 
sociodemographic factors were the focus of the research questions (Glanz, Champion, & 
Strecher, 2002). Research Questions 1 through 4 sought to assess participants’ 
perceptions of severity, risk, susceptibility to the seasonal influenza virus and vaccine, 
and vaccine benefits and barriers (Coe, Gatewood, Moczygemba, Goode, & Beckner, 
2012; Glanz, Rimer, & Lewis, 2002). Research Questions 5 through 7 sought to assess 
mediating factors that include demographic variables (age, gender, ethnicity, and 
occupation) associated with the perceptions of the influenza vaccine (Lenzi, Wiens, 
Grochocki, & Pontarolo, 2011). Mediator factors also included self-assessment of the 
ability to successfully accept the influenza vaccine and external influences such as media 
advertisement and flyers; information sorted by older adults or information provided by 
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clinicians, family, caregivers, or persuasive communications; and personal experience 
that led to the uptake of the influenza vaccine. 
Research Question 1. Is there a significant relationship between older adults 
perceived susceptibility to the seasonal influenza and frequency and recency of vaccine? 
H10: There is no significant relationship between older adults perceived 
susceptibility to the seasonal influenza and frequency and recency of vaccine.  
H1A: There is a significant relationship between older adults perceived 
susceptibility to the seasonal influenza and frequency and recency of vaccine. 
Research Question 2. Is there a significant relationship between older adults 
perceived severity to seasonal influenza based on CDC influenza guidelines? 
H20: There is no significant relationship between older adults perceived severity 
to seasonal influenza based on CDC influenza guidelines.  
H2A: There is a significant relationship between older adults perceived severity to 
seasonal influenza based on CDC influenza guidelines.  
Research Question 3. Is there a significant relationship between older adults 
perceived benefits and the positive consequences of the annual seasonal influenza 
vaccine uptake? 
H30: There is no significant relationship between older adults perceived benefits 
and the positive consequences of the annual seasonal influenza vaccine uptake.  
H3A: There is a significant relationship between older adults perceived benefits 
and the positive consequences of obtaining the annual seasonal influenza vaccine.  
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Research Question 4. Is there a significant relationship between older adults 
perceived barriers and discouragement concerning the uptake of the seasonal influenza 
vaccine?  
H40: There no significant relationship between older adults perceived barriers and 
discouragement concerning the uptake of the seasonal influenza vaccine.  
H4A: There is a significant relationship between older adults perceived barriers 
and discouragement concerning the uptake seasonal influenza vaccine.  
Research Question 5. Is there a significant relationship between older adults 
perceived cues to action and health care providers’ persuasive communications about 
seasonal influenza vaccine?  
H50: There is no significant relationship between older adults perceived cues to 
action and health care providers’ persuasive communications about seasonal influenza 
vaccine.  
H5A: There is a significant relationship between older adults perceived cues to 
action and health care providers’ persuasive communications about seasonal influenza 
vaccine.  
Research Question 6. Is there a significant relationship between older adults 
perceived self-efficacy and the ability to successfully obtaining the seasonal influenza 
vaccine?  
H60: There is no significant relationship between older adults perceived self-
efficacy and the ability to successfully obtaining the seasonal influenza vaccine.  
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H6A: There is a significant relationship between older adults perceived self-
efficacy and the ability to successfully obtaining the seasonal influenza vaccine.  
Research Question 7. Is there a significant relationship between full HBM 
constructs plus mediating demographic factors such as age, gender, ethnicity, occupation, 
and older adults’ perceptions of the seasonal influenza vaccine?  
H70: There is no significant relationship between full HBM constructs plus 
mediating demographic factors such as age, gender, ethnicity, occupation, and older 
adults’ perceptions of the seasonal influenza vaccine.  
H7A: There is a significant relationship between full HBM constructs plus 
mediating demographic factors such as such as age, gender, ethnicity, occupation, and the 
elderly perceptions of acceptance of the seasonal influenza vaccine.  
Research Question 8. Is there significant relationship between influenza vaccine 
recency and influenza disease among older adults? 
H80: There is no significant relationship between influenza vaccine recency and 
influenza disease among older adults. 
H8A: There is a significant relationship between influenza vaccine recency and 
influenza disease among older adults. 
Research Question 9. Is there a significant relationship between influenza disease 
frequency and influenza vaccine uptake among older adults? 
H90: There is no significant relationship between influenza disease frequency and 
influenza vaccine uptake among older adults. 
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H9A: There is a significant relationship between influenza disease frequency and 
influenza vaccine uptake among older adults.  
Theoretical Base 
The HBM was developed in the 1950s by Hochbaum, Rosenstock, and Kegels, a 
group of public health researchers, in response to a health screening program for 
tuberculosis (as cited in Rosenstock, 1966). The model was originally designed to predict 
behavioral responses to the treatment received by acutely or chronically ill patients; 
however, in recent years, the model has been used to predict general health behaviors 
(Ogden, 2007). To accommodate evolving evidence that knowledge and perceptions 
played a role in personal responsibility, the model was amended (Glanz, Lewis, & Rimer, 
2002). The HBM suggests that the belief in a personal threat together with the belief in 
the effectiveness of the proposed behavior will predict the likelihood of that behavior 
(Rosenstock, Strecher, & Becker, 1988). The HBM was used in many psychological and 
medical studies to help determine an individual’s health thoughts, behaviors, and 
wellness (Glanz, Rimer, & Lewis, 2002). Applying the HBM to this study has helped in 
providing context of the older adults’ perceptions of the influenza vaccine. 
The major theoretical propositions of the HBM are based on core assumptions 
that health-related actions are taken when a person believes that a negative health 
condition can be avoided. In addition, a positive expectation exists that taking a 
recommended action will prevent a negative health condition or that a recommended 
health action can be successfully taken comfortably and with confidence (Glanz et al., 
2002). The six constructs of the HBM are perceived susceptibility, perceived severity, 
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perceived benefits, perceived barriers, cues to action, and self-efficacy. The four 
constructs, perceived susceptibility, perceived severity, perceived benefits, and perceived 
barriers, represent the perceived threat and net benefits, which account for a person's 
readiness to act. Two constructs that represent the challenges of changing habitual 
unhealthy behaviors are cues to action, or activation of readiness and stimulate an overt 
behavior, and self-efficacy, which represents a person’s confidence in the ability to 
perform an action successfully (Rosenstock et al., 1988). These theoretical propositions 
of the HBM supported the hypotheses and are discussed further in Chapter 2. 
Operational Definitions 
 Demographic mediating factors: Refer to modifying variables such as age, sex, 
race, ethnicity, and education that may interfere with influenza vaccine uptake indirectly 
by affecting perceived susceptibility, benefits, barriers, cues to action, and self-efficacy 
(Glanz, Marcus Lewis, & Rimer, 1997; Glanz, Rimer, & Viswanath, 2008).   
Frequency of influenza disease: Measurement of the most recent episode of 
influenza disease within 1 year or less (CDC, 2013). 
Health belief model: The health belief model (HBM) was one of the first health 
behavior theories developed in the 1950s by a group of U.S. Public Health Service social 
psychologists to explain the reasons why only few people participated in health screening 
programs. Since then, the HBM has been widely used in a variety of health behavior 
research. The HBM addresses the three distinct areas of perception: perceptions of the 
threat posed by a health problem (susceptibility, severity), the benefits of avoiding the 
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threat, and factors influencing the decision to act (barriers, cues to action, and self-
efficacy; National Cancer Institute; NCI 2005). 
Influenza complications: Complications of influenza can include bacterial 
pneumonia, ear infections, sinus infections, dehydration, and worsening of chronic 
medical conditions, such as congestive heart failure, asthma, or diabetes (CDC 2012 -
2013). 
Influenza disease: Defined as an infectious respiratory disease caused by the 
influenza viruses, Types A, B, and C. Types A and B are known as human influenza 
viruses that cause seasonal influenza disease almost every winter in the United States. 
Influenza virus Type C causes mild respiratory illnesses and is not thought to cause 
influenza epidemics (CDC, 2012).  
Influenza vaccine: The mandatory vaccine administered to protect against the 
three influenza viruses. The various types of influenza vaccines available are the trivalent 
inactivated vaccine (TIV) and the live-attenuated influenza vaccine (LAIV). There are 
three different influenza vaccines available: a regular influenza vaccine approved for 
people ages 6 months and older, a high-dose influenza vaccine approved for people 65 
and older, and an intradermal influenza vaccine approved for people 18 to 64 years of age 
(CDC 2012-2013; Food and Drug Administration (FDA), 2012).   
Influenza virus: The CDC 2013-2014 has reported three types of influenza 
viruses: Types A, B, and C. Type A and B are human influenza viruses that cause 
seasonal the seasonal influenza disease almost every winter in the United States. 
Influenza Type C causes mild respiratory illnesses and is not thought to cause influenza 
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epidemics. Influenza A viruses are divided into subtypes based on two proteins on the 
surface of the virus: the hemagglutinin (H) and the neuraminidase (N). The current 
subtypes of the influenza A virus that have been identified in humans are influenza A 
(H1N1) and influenza A (H3N2) viruses (CDC 2009). There is no provision for 
describing distinct subtypes of influenza B and C viruses. The existence of antigenic 
variation among influenza B strains is well established, but the available information 
shows that a division into subtypes is not warranted (World Health Organization (WHO), 
1990). 
Older adults: For the seasonal influenza immunization administration, the elderly 
is described as the group of people aged 65 or older because they are disproportionately 
affected by the influenza related complications (Sullivan, Jacobson, & Poland, 2010). 
Perceived barriers: An individual’s opinion of what is preventing from making 
the decision to adopt a new behavior that can protect and prevent influenza disease 
(Glanz et al., 1997). 
Perceived benefits: An individual’s beliefs about the safety and effectiveness of 
taking the influenza vaccine to reduce risk of getting influenza and the related 
complication (Glanz et al., 2002).  
Perceived cues to action: A trigger that is necessary for prompting engagement in 
the decision-making process to accept a recommended influenza vaccine (Glanz et al., 
1997).  
Perceived self-efficacy: An individual's perception of his or her competence to 
successfully act in seeking the influenza vaccine (Glanz et al., 1997; Glanz et al., 2008).  
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Perceived severity: An individual's beliefs about the seriousness of influenza 
disease and how to avoid it (Glanz et al., 1997; NCI, 2005). 
Perceived susceptibility: An individual’s beliefs about the chances of getting 
influenza disease (Glanz et al., 1997; NCI, 2005). 
Recency of influenza vaccine uptake: Measurement of the most recent influenza 
vaccine uptake within 1 year or less (CDC, 2013). 
Assumptions 
The assumptions are necessary in the context of this study because it is presumed 
that the study is objective, generalizability is possible, and other studies can be replicated 
from this study. 
The following are the assumptions of this study: 
● Participants have answered the interview questions appropriately by giving a 
true and sincere representation of their perceptions of influenza disease and 
influenza vaccine. 
● Participants have answered the interview questions and provided appropriate 
answers that most closely represent their current influenza vaccination status.  
● The HBM has been an adequate model to describe the participants’ 
perceptions of the influenza disease and the influenza vaccine.  
● The senior citizen centers have been an adequate setting for the study.  
● The research instrument used in this study was adequate and appropriate to 
capture the data needed to describe and categorize the participants’ perception 
of influenza disease and influenza vaccination.  
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Limitations 
In every study, there is a possibility of limitations. Since I used a cross-sectional 
design, there is a possibility that there can be a limitation with the strength of the internal 
validity. Additional limitations included (a) self-reporting for seasonal influenza 
vaccination status, (b) participants’ responses to demographic and instrument questions 
only, (c) male and female participants aged 65 and older and who are enrolled in the 
selected senior centers in Brooklyn, New York, (d) self-evaluation type of assessment of 
the instrument, and (e) voluntary participation from both males and females aged 65 and 
older who attended the selected senior centers in Brooklyn, New York. The possible 
biases that could influence study outcomes were nonresponses. To minimize this type of 
bias, the sample size was large enough to estimate the prevalence of the influenza vaccine 
uptake among the older adults in the selected demographic areas of Brooklyn. 
Delimitations 
The de-limitations of this study are as follows: 
1. This study was restricted to seniors who were identified as age 65 or older. 
2. This study was restricted to participants recruited through the three senior 
centers in Brooklyn. 
3. This study was restricted to seniors who read and write English. 
4. This study was restricted to seniors free of cognitive impairment and who 
could independently make appropriate decisions.  
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5. The study was generalized to all three senior centers because the older adults 
are of different racial/ethnic backgrounds, which are similar for each of the 
representing senior centers.  
Significance of the Study 
This study contributes to the body of knowledge related to perceptions of older 
adults concerning seasonal influenza vaccine uptake. Identifying health care providers’ 
communication with their patients about the importance of the influenza vaccine safety 
and effectiveness can increase the vaccine uptake among this age group. Because older 
adults are a high-risk group, such information may be valuable to encourage older adults 
to receive the influenza vaccination and therefore significantly reduce the incidence, 
complications, cost, and death from influenza and associated conditions. The potential 
implications for positive social change bounded by the scope of this study are providing 
senior public health decision makers and direct care clinicians with informed knowledge 
of the benefits and limitations of influenza screening and immunization of the older adult 
population and bringing about improvement in communication between clinicians and 
their patients about the importance of the annual seasonal influenza vaccine. 
Summary and Transition 
Influenza is a common respiratory illness that affects all humans when they are 
exposed to the influenza virus. Older adults are particularly vulnerable because they are 
in the high-risk category due to their age and existing chronic health conditions (CDC, 
2012-2013). According to the CDC (2010), the annual influenza vaccine is the best 
method for preventing influenza. However, despite the various methods of 
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communication used to raise awareness about the benefits of the influenza immunization, 
the immunization rate remains low among older adults. In this study, I examined factors 
associated with influenza vaccination among older adults in Brooklyn, New York. The 
purpose of the study was to determine what factors contribute to the decision to obtain 
the influenza immunizations among older adults. 
The HBM was used as the theoretical framework for this study because it 
supported the problem, purpose, background, research questions, and research design 
decisions, such as the method of inquiry and data collection. Chapter 2 contains a review 
of relevant literature pertaining to factors influencing vaccination status among older 
adults. 
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Chapter 2: Literature Review 
Overview 
The purpose of this study was to identify perceived factors that may be associated 
with poor influenza vaccination uptake among older adults. Despite the availability of the 
influenza vaccine, the number of older adults who should be protected from influenza 
disease by uptake of the influenza vaccine is far below the national health goals (CDC, 
National Center for Health Statistics, 2009). A review of relevant literature indicated that 
influenza related complications, hospitalization, and death among older adults is greater 
in Brooklyn and New York City, which is due to a decline in uptake of the influenza 
vaccine among older adults (SUNY Downstate Medical Center, 2010). Using the HBM, I 
sought to understand older adult motivation and decision-making about obtaining the 
influenza vaccine. 
This literature review, focused on the six constructs of the HBM: perceived 
susceptibility to influenza, perceived severity of influenza, perceived benefits of 
accepting the influenza vaccine, perceived barriers to obtaining the influenza vaccine, 
cues to action (Shahrabani & Benzion, 2012). These constructs relate to the strategies to 
activate readiness such as primary caregivers’ communication and reminders about 
vaccine importance and availability, providing information to promote awareness. An 
additional construct of the HBM is self-efficacy, which focuses on the confidence in the 
participant’s ability to take an action in obtaining the influenza vaccine. In addition to 
these HBM related constructs, timing of receipt of influenza vaccine (recency) within 1 
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year and frequency of influenza disease within the current season are important 
determinants of prevention.  
The findings in the literature are presented according to the construct of the HBM. 
The HBM literature synthesis is preceded with an overview of influenza and its 
complications, influenza vaccine guidelines and recommendations, vaccine effectiveness, 
side effects, contraindications, recommendations, and economic impact of influenza 
disease. A review of current literature was done as well as its application to this study. 
The literature review follows and includes studies on influenza vaccine uptake among 
older adults both at national and international levels.  
Literature Search Strategy 
An extensive search was conducted, using key words such as older adults, health 
belief model, influenza, influenza complication, influenza vaccine, influenza viruses, 
perception, perceived severity, perceived susceptibility, perceived benefits, perceived 
barriers, cues to action, self-efficacy, demographic mediating factors, frequency of 
influenza disease, and recency of influenza vaccine uptake within 1 year or less. The 
scope of literature reviewed included literature from 2007 to 2014; however, since the 
HBM is a sentinel model, some of the literature reviewed dates to the 1960s. The types of 
literature and sources searched were PubMed: biomedical literature citations and 
abstracts, including Medline--articles from medical and peer-reviewed journals including 
abstracts, PubMed Central, and other full-text resources that provided free, full text 
journal articles. The United States National Library of Medicine (NLM) at the National 
Institutes of Health was accessed; Google Scholar, a freely accessible web search engine 
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with full text of scholarly literature of various publishing formats and disciplines, 
including peer-reviewed online journals, scholarly books, and articles from scholarly 
publishers in the United States and other continents of the world. 
Theoretical Foundation 
The HBM was one of the first social cognition models developed in the 1950s 
(Janz & Becker, 1984) to evaluate the uptake of preventive health services and to predict 
health behavior change (Rosenstock, 1966). Further development of the HBM was done 
to accommodate the evolving evidence that was generated within the healthcare 
community about the role knowledge and perceptions played in a person’s personal 
responsibility about health (Glanz et al., 2002). In recent years, the HBM was used to 
predict more general health behaviors (Ogden, 2007). 
The HBM was systematically evaluated by established criteria in evaluating 
health behaviors. Since health behaviors are evaluated in this study, the HBM was 
considered a better model to explore the hypotheses of this study to show that there is a 
relationship among perceived reasons for limited uptake of the influenza vaccine (Glanz, 
Marcus Lewis, & Rimer, 1997). The key constructs of the HBM are perceived 
susceptibility-- individual's opinion of chances of getting a condition, perceived severity  
beliefs about the seriousness of a condition and its consequences, perceived benefits--
beliefs about the effectiveness of taking action to reduce risk or seriousness, perceived 
barriers--beliefs about the material and psychological costs of taking action to prevent the 
disease, cues to action--factors that activate readiness to change the behavior, and self-
efficacy--confidence in one’s ability to take action (Glanz, Rimer, & Lewis, 2002). The 
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HBM also focuses on other determinants such as demographic variables that include age, 
sex, race/ethnicity, income, education, and place of residence as well as personality. 
These determinants may indirectly influence how people perceive their risk to diseases 
(Becker, Champion 1984; Eisen, Zellman, & McAlister 1992; Glanz et al., 2002; Janz & 
Becker 1984, Rosenstock, & Slack 1974; 1985; Walter et al., 1992). 
The HBM was used as the theoretical base for this study to explain and predict 
health behaviors by focusing on the attitudes and beliefs concerning why older adults do 
not obtain the influenza vaccine. In relation to this study, the constructs of the HBM and 
the perceived threat of influenza were analyzed, along with the perceived decision to 
participate in health-seeking behavior of receiving the influenza vaccine. 
The delineation of assumptions appropriate to the application of the HBM for this 
study are that people fear disease, and the health actions are motivated by the degree of 
their fears and benefits that will bring about behavior change (Becker et al., 1974; 
Champion 1984; Eisen et al., 1992; Janz & Becker 1984, 1985; Walter et al., 1992). Each 
of the key constructs of the HBM was analyzed in three parts: (a) the individual’s 
perceptions of the threat posed by a health problem (susceptibility, severity), (b) the 
benefits of avoiding the threat, and (c) factors influencing the decision to act (barriers, 
cues to action, and self-efficacy; Janz, & Becker, 1984). 
 The HBM was selected for this study because it predicts preventive health 
behavior by examining belief patterns, and it focuses on the relationship between health 
behaviors and the perception of using available health services. It was largely tested 
empirically, and its application may help public health and health care professionals to 
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develop appropriate strategies to help the older adults in making informed decisions 
about the uptake of the influenza vaccine. In addition, the HBM was selected for this 
study to examine whether health care professionals’ recommendations about the seasonal 
influenza vaccination were significant predictors of patients’ intention to get vaccinated 
the vaccine. Figure 1 explains the theoretical preposition of the HBM and provides a way 
to understand and predict how an individual may behave in relation to his or her health 
and how he or she may comply with preventive health care practices. 
 
Figure 1: Uptake of Seasonal Influenza Vaccine among Older Adults based on the new 
health belief scale model for influenza vaccine uptake.  
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Epidemiology of Seasonal Influenza 
The seasonal influenza disease occurs annually in the United States and other 
temperate zones during the late fall through early spring (CDC, 2010; World Health 
Organization (WHO), 2009). Hospitalizations and deaths occur among the high-risk 
population to include the elderly and other high-risk groups (CDC, 2010). The mortality 
indicator for all ages exceeded the epidemic threshold because these rates are higher 
when compared to the same time last season (CDC 2013-2014).  
Worldwide, the influenza epidemic resulted in about 3,000,000 to 5,000,000 cases 
of severe illness, and about 250,000 to 500,000 deaths (CDC, 2012; WHO, 2009). 
Influenza together with pneumonia is the eighth leading cause of death in the United 
States and the fifth leading cause of death among those 65 years old and older 
(Kochanek, Xu, Murphy, Miniño, & Kung, 2011) while it is the third leading cause of 
death in New York City New York City Department of Health and Mental Hygiene 
(NYCDHMH), 2010). Most of these deaths are associated with influenza complications, 
which occur among people age 65 or older (CDC, 2012-2013, WHO, 2009). The CDC 
(2010) reported that over a period of 31 seasons, between 1976 and 2007, the estimates of 
influenza associated deaths in the United States ranged from a low of about 3,000 to a 
high of about 49,000 people. Influenza and pneumonia deaths increase with age. More 
than 85% of deaths from influenza and pneumonia occurred among people over 65 in 
Brooklyn and the rest of New York City (State University of New York (SUNY) 
Downstate Medical Center, 2010). 
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To estimate the health burden associated with the circulation of influenza viruses, 
the CDC uses a 7-component national surveillance system for influenza that includes 
virologic, influenza-like illness, hospitalization, and mortality data. These data were used 
in statistical models to estimate the possible impact of future pandemics influenza 
occurrences. Improving surveillance of influenza helps the CDC and their partners in 
different parts of the world including the United States in monitoring the various strains 
of influenza that are currently circulating. This type of evidence is needed to detect the 
type of circulating viruses, which contribute to appropriateness of the influenza vaccines 
that are produced (CDC, 2010). 
Every year the occurrences of seasonal influenza place a heavy demand on the 
economy and healthcare resources due to the increase in health care consultations, 
hospitalizations, clinical complications, and patient treatment that are seen particularly in 
the high-risk groups (CDC, 2013). Molinari, et al. (2007) reported that the economic 
burden of influenza on the society has been estimated to be $87.1 billion each year, 
which includes an average of $10.4 billion in direct medical costs. Unlike countries in the 
temperate regions of the world, in some tropical countries, influenza viruses circulate 
throughout the year with one or two peaks during rainy seasons (WHO, 2009).   
Pathophysiology of Seasonal Influenza, Regulation, and Influenza 
Seasonal influenza is an acute contagious respiratory infectious disease caused by 
a member of the Orthomyxovirus family, which includes influenza virus A, B, or, to a 
much lesser extent, C (CDC, 2013-2014). Several studies reported that the influenza virus 
could be transmitted through several distinct mechanisms, such as large droplets from an 
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infected person, aerosols, and direct contact with contaminated hosts and surfaces 
(Brankston et al. 2007; Tellier 2009; Weber & Stilianakis, 2008). Seasonal influenza 
causes mild to severe illness, which causes hospitalization and can lead to death (CDC, 
2013-2014; WHO, 2009). Influenza virus is usually replicated in the epithelial cells 
throughout the respiratory tract, with the virus being recoverable from both the upper and 
lower respiratory tract of people naturally or experimentally infected (Wright, Neumann, 
& Kawaoka, 2007). The influenza virus is different from a cold (CDC, 2012). Influenza 
symptoms usually occur suddenly once a person is infected with the influenza virus 
(CDC 2013). The CDC (2013) reported that some or these symptoms are usually reported 
by persons infected with the seasonal influenza virus are fever and chills, cough, sore 
throat, runny or stuffy nose, muscle or body aches, headaches, and fatigue. Other 
symptoms reported are vomiting and diarrhea, which is more common in children than 
adults. Although fever is one of the most common symptoms reported, not everyone with 
influenza will have a fever (CDC, 2012-2013, WHO, 2009). 
Most people who are infected with the seasonal influenza virus will recover in a 
few days to less than 2 weeks, but many will develop complications such as pneumonia, 
which can be life threatening and result in death (CDC, 2012-2013; WHO, 2009). 
Influenza can occur at any age, but some people are at a higher risk of developing serious 
influenza-related complications, including people 65 years and older, people of any age 
with certain chronic medical conditions such as asthma, diabetes, or heart disease, 
pregnant women, and young children (CDC 2012). The most common complications 
reported because of the seasonal influenza are pneumonia, bronchitis, and sinus and ear 
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infections. Influenza complications are worst among people with chronic health problems 
(CDC 2010; National Center for Biotechnology Information (NCBI), 2009). People with 
asthma may experience asthma attacks while those with chronic congestive heart failure 
may have worsening of a condition that is triggered by the influenza (CDC, 2013). 
However, the most frequent serious influenza complication is pneumonia, which is 
categorized into four different types: primary influenza pneumonia, secondary bacterial 
pneumonia, pneumonia due to unusual pathogens in immune-compromised hosts, and 
exacerbations of chronic pulmonary diseases (CDC, 2013; WHO, 2009). The most 
common bacterial pathogens reported are Streptococcus Pneumoniae, Staphylococcus 
Aureus, and Haemophilus Influenzae, which act synergistically with the influenza virus 
through the increased binding and invasion of bacteria, increased viral replication, and 
modification of the host inflammatory response (CDC, 2012; Rothberg, Haessler, & 
Brown, 2008). 
The severity of the influenza virus can vary widely from one season to another 
depending on the circulating influenza viruses, influenza vaccine(s) availability, the 
number of people vaccinated, and how well the influenza vaccine matched circulating 
influenza viruses (CDC, 2013). Many people die from seasonal influenza each year in the 
United States (CDC, 2012). A report in the CDC 2010 provided updated estimates of the 
range of influenza-associated deaths that occurred in the United States during the 3 
decades prior to 2007. These estimates indicated that influenza-associated deaths ranged 
from 3,000 to 49,000 between 1976 and 2007 (CDC, 2010). Death certificate data and 
weekly influenza virus surveillance were used to estimate how many flu-related deaths 
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occurred among people whose underlying cause of death was listed as respiratory or 
circulatory disease on their death certificate (CDC MMWR 2010, 1057-1062).  
The most important method of controlling the seasonal influenza is the annual 
influenza vaccination, considered the best method for preventing and controlling seasonal 
influenza (CDC, 2012). In addition, the role the annual influenza vaccine plays a key 
strategy in assisting the population in preparing for pandemic influenza outbreaks (CDC, 
2012). Since influenza is a very infectious disease, older adults, children under the age of 
2, and the population with chronic diseases such as diabetes, kidney failure, 
cardiopulmonary, and immunocompromised diseases are prone to suffer severely from 
influenza (CDC, 2013). In addition, people who are morbidly obese and American 
Indians/Alaskan Natives have been classified in recent studies as high risk groups for 
influenza complications (Jain, Bairoch, Duvaud, Phan, Redaschi, Suzek, Martin, 
McGarvey, Gasteiger, 2009; Morgan et al., 2010). The effects of the serious outcome of 
influenza on older adults require that they must receive the influenza vaccine as 
recommended by the CDC (2014).  
The Health Belief Model 
The HBM has been applied in many psychological and medical studies all over the 
world with varying success to problems about explaining, predicting, and influencing 
behavior (Janz & Becker, 1984). The health belief model to date remains of the most 
widely used and well-tested models for explaining and predicting health-related 
behaviors (Carpenter, 2010). Since the health belief model has been used in the past to 
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predict a wide variety of health-related behaviors such as screening for early detection of 
asymptomatic diseases and immunizations uptake it was a suitable fit for this study.    
According to Janz, Marshall, Becker (1984) the constructs of the health belief model; 
perceived susceptibility, perceived severity, perceived benefits, perceived barriers, 
perceived cues to action and perceived self-efficacy are proposed to vary between 
individuals and their engagement in health-related behaviors such as getting screened for 
asymptomatic diseases and immunization uptake.  The model has also been applied to 
many studies to understand the participants’ responses to symptoms of disease, 
compliance with their medical regimens, and lifestyle behaviors changes in areas such as 
sexual risk behaviors and behaviors related to chronic illnesses (Janz, Marshall, Becker, 
1984; Glanz, Rimer, Viswanath, 2008).  
Rosenstock (1974) and Janz, Marshall, Becker (1984) reported that the health belief 
model suggests that the interventions based on the perceived health behavior may aim to 
increase perceived susceptibility to a disease and perceived severity of a health condition 
by providing education about prevalence and incidence of disease, estimates of risk, and 
information about the medical, financial, and social consequences that may change the 
health-related behaviors.  Perceived benefits of action, perceived barriers to action, and 
perceived self-efficacy may predict the engagement or lack of engagement in an health-
promoting behavior while the construct cue to action, must be present to trigger the 
required health-promoting behavior (Carpenter, 2010). Other areas that are represented 
on the health belief model and need evaluation when using the model are the modifying 
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demographic factors outside that may prevent the individual engagement in the desired 
health behaviors (Janz, Marshall, Becker, 1984). 
A survey conducted in a dwelling community of older adult Greeks who were 
having routine access to medical care, identified main reasons and barriers for influenza 
vaccine uptake. These included recommendations from health care professionals, beliefs 
about the benefits of influenza vaccination, having a relative who delivered the vaccine, 
younger than 75 years old, having unpleasant reactions in the past, lack of adequate 
information about the side effects of influenza vaccine, and vaccine shortages 
(Raftopoulos, 2007).  
Banach, Ornstein, Factor, and Soriano (2012) reported that factors associated with 
refusal of the influenza vaccine was positively associated with female gender, African 
American (Black) race, and living alone; while non-acceptance was negatively associated 
with dementia. Studies have reported that after educational sessions about breast self-
examination and clinical examination, practice rates increased (Hajian, Vakilian, 
Najabadi, Hosseini, Mirzaei, 2011). Another study reported that those who indicated that 
prior vaccination against seasonal influenza reported significantly higher H1N1 
vaccination intentions than those who had not been vaccinated (Gidengil, Parker, 
Zikmund-Fisher, 2011).  
The HBM was successfully used in a study to determine the effectiveness of the 
HBM on nutrition education among Type 2 diabetic patients attending Iranian Diabetes 
Association seminars and reported knowledge scores increased in the intervention group 
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compared to the control group after the intervention was carried out (Sharifirad, Entezari, 
Kamran, Azadbakht, 2009).  
Influenza Vaccination Uptake Among Older Adults in Brooklyn, New York 
New York City Community Health Survey carried out over two-years in 
Brooklyn New York was based on the Healthy People 2010 initiative. This initiative set 
national goals of achieving a 90 percent rate of immunization against pneumococcal 
pneumonia for persons over 65. The survey findings indicated that immunization rates 
were far below the national goal for those reported in a national survey. The report from 
the survey indicated that 50% of respondents over the age of 65 in New York City and 
56% of Brooklyn residents had never been vaccinated (Community Health Survey, 
2008). 
The factors as indicated that increased the likelihood of being hospitalized with 
pneumonia among the older adults were low immunization rates, underlying health 
conditions, and poor access to preventive services. Higher hospitalization rates for people 
over 65 were observed in several neighborhoods with a greater percentage of older adult 
residents. The hospitalization rate when compared by race and ethnicity indicated that 
among the over-65 age group, African Americans (Blacks) had a higher hospitalization 
rates, followed by Hispanic, European Americans (Whites) residents, Asian and Pacific 
Islanders who had lower rates. However, the report indicated Brooklyn had lower rates of 
hospitalization for pneumonia than the rest of New York City except for African 
Americans (Blacks) Brooklyn residents (2008 Community Health Survey). 
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Seasonal Influenza Vaccine Guidelines 
The CDC 2010 reported that older adults age 65 years and older are at greater risk of 
serious influenza complications compared to young, healthy adults. 90 percent of 
seasonal influenza-related deaths and more than 60 percent of seasonal influenza-related 
hospitalizations in the United States each year occur among people age 65 years and 
older (CDC, 2010). Prevention and immediate treatment of influenza among the older 
adults may decrease the risk of influenza-associated complications, hospitalization and 
death (CDC, 2012-2013). 
Influenza vaccination remains one of the most effective defenses against the 
influenza infection and its associated complications (CDC, 2009). The CDC Advisory 
Committee on Immunization Practices (ACIP) recommends the use of influenza vaccine 
for the prevention and control of influenza (CDC, 2010). High-risk groups recommended 
to receive the influenza vaccine are disabled, people in nursing homes, older adults 65 
years or older, and individuals with chronic medical conditions. In addition, other groups 
such as pregnant women, health care workers, those with essential functions in society, as 
well as children from ages six months to two years are also included in this 
recommendation (CDC's Advisory Committee on Immunization Practices [ACIP], 2009; 
WHO, 2009).  
Without preference, the CDC has recommended two types of influenza vaccine 
for people 65 and older: a regular trivalent inactivated vaccine (TIV) and the Fluzone 
High-Dose vaccine (add citation CDC, 2013). TIV is administered intramuscularly in the 
deltoid muscle. Fluzone High-Dose is designed specifically for people age 65 years and 
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older. Fluzone High-Dose vaccine contains a higher dose of antigen than regular 
influenza shots, and this may give older people a better immune response to the vaccine 
(CDC, 2013).  
The most common adverse events reported to TIV Vaccine Adverse Event 
Reporting System (VAERS) in adults included injection-site reactions, pain, fever, 
myalgia, and headache. The TIV VAERS review identified no new safety concerns; 
however, the most common serious adverse event reported after receiving TIV VAERS 
in adults was Guillain-Barré Syndrome (GBS) (CDC, 2012-2013). According to the CDC 
(2012-2013), the potential association between TIV and GBS has been an area of ongoing 
research. Injection-site reactions and systemic adverse events among older adults are 
most frequently reported after vaccination with the Fluzone High-Dose Sanofi Pasteur 
(CDC, 2012-2013). When compared with a standard dose of Fluzone, Sanofi Pasteur 
vaccines which contained 45 mcg HA and the Fluzone High-Dose Sanofi Pasteur which 
contains 180 mcg of Hemagglutinin HA antigen the side effects of Fluzone High-Dose 
Sanofi Pasteur were typically milder and transient (CDC, 2012-2013). 
Seasonal Influenza Treatment Guidelines 
The CDC 2012-2013 recent report on seasonal influenza hospitalization shows an 
increase in hospitalization and death among the older adults. The influenza-associated 
hospitalization rate for persons 65 and older was 82 per 100,000, an increase from 69.8 
per 100,000 during the prior week. When compared to the same time last season, which 
was milder, the influenza-associated hospitalization rate for persons 65 and older remains 
within the expected prediction for a moderately severe season (CDC 2012-2013). Among 
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laboratory-confirmed influenza hospitalizations, 50% of those hospitalized have been 
among persons 65 and older (CDC 2012-2013). Influenza-associated mortality indicators 
also increased sharply among all age groups this season with 80 percent of cumulative 
deaths had occurred among people 65 years or older. 
The CDC has recommended antiviral treatment as an adjunct therapy to reduce 
the duration of illness and complications associated with influenza. The antiviral therapy 
is recommended for all persons 65 and older with suspected influenza, regardless of the 
severity of illness. Treatment of antiviral therapy must be given immediately, preferably 
within 48 hours after illness onset. Among hospitalized patients, treatment should be 
initiated on admission regardless of onset of symptom. In addition, CDC 2012-2013 has 
recommended that the decision to initiate antiviral treatment should be done regardless of 
vaccination status and clinicians should not wait on laboratory confirmation of influenza 
before initiating antiviral therapy (CDC 2012-2013).   
The CDC has recommended the use of Oseltamivir or Zanamivir as the primary 
antiviral agents for the prevention and treatment of influenza in the United States during 
the 2012-2013 influenza season (CDC, 2012-2013). The CDC reported resistance to 
Oseltamivir and Zanamivir among circulating influenza viruses is currently low, but this 
finding can change since antiviral resistance can emerge during or after treatment in 
patients who are immunosuppressed (CDC, 2013-2014). Both Oseltamivir and Zanamivir 
are chemically related antiviral medications known to have activity against both the 
influenza A and B viruses. The best clinical outcome occurs when the antiviral therapy is 
administered early, within 48 hours of influenza illness onset (CDC, 2013-2014). 
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Reported adverse events of Oseltamivir are nausea, vomiting, Sporadic, transient 
neuropsychiatric events to include self-injury or delirium which was mainly reported in a 
study done among Japanese adolescents and adults (CDC, 2013-2014). Adverse event 
that were reported for Zanamivir were diarrhea, nausea, sinusitis, nasal signs and 
symptoms, bronchitis, cough, headache, dizziness, and ear, nose and throat infections. 
Oropharyngeal or facial edema was reported as an allergic reaction to Zanamivir (CDC, 
2013-2014). 
The Economic Impact of Influenza 
The influenza epidemic continues to pose a serious economic impact on our 
society due to increase cost in health care for persons infected with the influenza virus, 
loss of productivity and death from influenza complications. Mao, Yang, Qiu, and Yang 
(2012) mapped county-level economic impacts of seasonal influenza in the U.S. on four 
county-based strategies. They suggested that prioritizing counties with high attack rates 
would produce the greatest cost-benefits annual economic impacts of seasonal influenza 
since the cost varied from $13.9 thousand to $957.5 million across U.S. counties, with a 
median of $2.47 million. Using important contributors such as hospitalization costs, lost 
productivity from missed work days and lost lives another study has reported that the 
total economic burden of annual influenza epidemics using projected statistical life 
values amounted to $87.1 billion (Molinari, Ortega-Sanchez, Messonnier, et al. 2007). 
Many studies have focused on the cost-effectiveness of seasonal influenza 
vaccination among the older adults age 65 years and older and reported that vaccination 
is cost effective if taken by older adults because it decreases doctors’ visits and 
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hospitalization (Postma, Baltussen, Palache, Wilschut, 2006). Other published studies 
have reported that influenza vaccination is likely to be cost-effective, however the results 
of these studies have found to be dependent on some key assumptions used in the 
economic evaluations (Newall, Kelly, Harsley, Scuffham, 2009). 
Key Constructs 
The HBM was applied to this study to predict the perception of the older adults 
concerning the influenza vaccine uptake. HBM scale constructs that served as the 
independent variables are: perceived susceptibility; perceived severity, perceived barriers, 
perceived benefits, and perceived cues to action, perceived self-efficacy, and mediating 
demographic factors. The dependent variables are recency of influenza vaccine uptake 
and frequency influenza disease within one year or less which represented the efficacy 
and effectiveness of influenza vaccination for possible outcome measures, including the 
prevention of influenza infection. As a general method of addressing perceived beliefs of 
the older adults and the efficacy and effectiveness of influenza vaccination, the literature 
review offers a useful structure for understanding a wider range of previous research 
findings on belief perception in similar situations. 
Perceived Susceptibility to Influenza Disease 
 Perceived susceptibility is an individual’s beliefs about the chances of getting 
influenza (Glanz, Marcus Lewis, & Rimer, 1997; NCI, 2005). In this study, perceived 
susceptibility is expressed in two forms those who believe they will benefit if they took 
the influenza vaccine because it will protect them from influenza and its complications 
and those who believe if they took the influenza vaccine they will get influenza. The aim 
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of the clinician is to identify their patients’ ‘belief about the chances of getting influenza 
when patients are not yet vaccinated, and tailor information about influenza vaccination 
based on their patients’ behaviors. This can help patients to develop an accurate 
perception of their own risk if they do not take the influenza vaccine (Glanz, Rimer, & 
Lewis, 2002).  Researchers have used the HBM to examine the factors associated with 
the intention to undergo specific health guidance using health insurance union members 
of a company in Japan and reported that perceived threat and net benefit were related to 
intention and net benefit had a stronger correlation with intention than did perceived 
benefit and barriers (Yamamoto, Mizoshita, and Akamatsu, 2002). Prior influenza 
vaccination was associated with higher perceived risk for influenza than unvaccinated; 
while those without prior influenza vaccine were unlikely to believe that they would get 
influenza (Brewer & Hallman, 2006; Mayo & Cobler, 2004; Nowalk, Zimmerman, Shen, 
Jewell & Raymund, 2004; Santibanez et al., 2002; Tabbarah et al., 2005; Telford & 
Rogers, 2003; Willis & Wortley, 2007; Zimmerman, Santibanez et al., 2003). Other 
studies have shown that individuals who were resistant to influenza vaccination were 
concerned about the susceptibility of vulnerable family members, and were willing to get 
vaccinated to protect the health of someone they cared about (Bardenheier et al., 2006; 
John & Cheney, 2008). 
Perceived Severity of Influenza Disease Seriousness 
Perceived severity is an individual’s belief about the seriousness of influenza 
disease and how to avoid it (Glanz, Marcus Lewis, & Rimer, 1997; NCI, 2005). During 
discussion with patients about the importance of influenza vaccination, clinicians must 
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specify the consequences of influenza and recommend the influenza vaccine, which is the 
most important preventive method available. Studies have reported that perceived 
severity is particularly important when susceptibility beliefs are high. Some studies 
argued that perceived severity cannot be used by itself as a significant predictor of 
influenza vaccination (Armstrong, Berlin, Schwartz, Propert, & Ubel, 2001; Blue & 
Valley, 2002; Brewer & Hallman, 2006). Other studies have reported that individuals 
whether they were vaccinated or unvaccinated, saw influenza infection as a serious 
illness, particularly for persons their own age (Chi & Neuzil, 2004; Lindley, Wortley, 
Winston, & Bardenheier, 2006). Ho, Huang, Huang, et al. 2008 examined the risk of 
adverse effects of special interest in persons vaccinated against seasonal influenza 
compared with unvaccinated persons aged 65 and above. They reported that vaccination 
was related to decreased risk for hospitalization.  
Perceived Benefit to Influenza Immunization 
Perceived benefit is the beliefs about the safety and effectiveness of taking the 
influenza vaccine to reduce risk of getting influenza disease and the related complication 
(Glanz, Rimer, & Lewis, 2002). The role of the clinician is explaining to their patients the 
potential positive results that may occur if they receive the influenza vaccine, how they 
can go about getting the vaccine, places where the vaccine is available, and reminding 
patients about the appropriate time to take the influenza vaccine (Glanz, Rimer & Lewis, 
2002).  
One of the most important benefits is the effectiveness of the vaccination why the 
vaccine is given every year is to reduce the risk or seriousness of influenza (CDC, 
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20010). Several studies have reported that perceived effectiveness of the influenza 
vaccine is one of the most consistent predictors of influenza vaccination uptake (Brewer 
& Hallman, 2006; Tabbarah et al., 2005). Müller and Szucs (2007) reported the three 
most frequent reasons why the elderly accepted the influenza vaccine were: influenza was 
a serious illness which people wanted to avoid, having received advice from the primary 
care physician or nurse to be vaccinated and not wanting to infect family and friends. 
Chiatti, Barbadoro, Lamura, Pennacchietti et al. (2011) surveyed a group of older adults 
Italian to examine the determinants of vaccine uptake. Their findings indicated that being 
over 85-years old and suffering from a severe chronic disease were the strongest 
determinants of vaccine uptake while relying on neighbors' support or on privately paid 
home help was also associated with a higher likelihood of vaccine uptake.  
Perceived Barriers to Influenza Immunization 
Perceived barriers is an individual’s opinion of what is stopping him or her from 
making the decision to adopt a new behavior that can protect and prevent influenza 
disease (Glanz, Marcus Lewis, & Rimer, 1997). Individuals who oppose the influenza 
vaccination are more likely to report experiencing vaccination side effects or getting sick 
from the influenza vaccination (Brewer & Hallman, 2006; Chi & Neuzil, 2004; John & 
Cheney, 2008; Lindley et al., 2006; Mayo & Cobler, 2004; Tabbarah et al., 2005; 
Winston, Wortley & Lees, 2006; Zimmerman, Santibanez et al., 2003). Previous studies 
have also documented knowledge barriers (Gosney, 2000; Lindley et al., 2006; Ritvo et 
al., 2003), and concern about safety of influenza vaccination are some of the predictors of 
poor vaccine uptake (Allison et al., 2010; Chen et al., 2011; John & Cheney, 2008; 
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Lindley et al., 2006; Telford & Rogers, 2003; Willis & Wortley, 2007; Wray et al., 2007). 
One study reported that despite these findings, about 48% of older adults who had 
concerns about the effectiveness of the influenza vaccine and 37% of those who believed 
that the influenza vaccine causes illness agreed to vaccinate to protect others 
(Bardenheier et al., 2006). Earlier studies have reported that some individuals who were 
not vaccinated believed that there were some benefits to vaccination; however, there were 
more concerns about costs over the benefits of the vaccine (Bardenheier et al., 2006; Chi 
& Neuzil, 2004; Nowalk et al., 2004; Zimmerman, Santibanez, et al., 2003). Clinicians’ 
role in helping to minimize such barriers is to reassure patients about the vaccine safety 
and effectiveness, which can assist in correcting any misinformation. Many barriers to 
immunization have been reported. Johnson, Nichol and Lipczynski (2008) reported that 
among the most common barriers to immunizations were lack of physician 
recommendations and mistaken assumptions while other reasons cited by healthcare 
providers were side effects, fear of needles, and lack of insurance coverage as reasons 
and practice issues, such as lack of an effective reminder system. Müller and Szucs 
(2007) reported that reasons for not accepting the vaccine among older adults who were 
never vaccinated included not expecting to contract influenza and not having considered 
vaccination as preventive measure.  
Cues to Action to Influenza Immunization 
Cues to action are a trigger that is necessary for prompting engagement in 
decision-making process to accept the recommended influenza vaccine (Glanz, Marcus 
Lewis, & Rimer, 1997). The cues to action are strategies to activate readiness which can 
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be described as events either bodily symptoms such as a physical symptom of a health 
condition or environmental such as media publicity that motivate people to act (Janz and 
Becker, 1984). In applying cues to action, health care practitioners’ role is to promote 
awareness by providing appropriate information and continuous reminders to patients to 
bring about health behavior change (Janz and Becker, 1984). This construct of the HBM 
has not received attention in many studies although it plays an important role in health 
behavior changes; however, cues to action can be an important practice strategy. Studies 
have reported that health care provider recommendations were associated with higher 
rates of influenza vaccination uptake (Allison et al., 2010; Chen et al., 2011; Mayo & 
Cobler, 2004; Winston et al., 2006) which are primarily one of the contributory factors 
for influenza vaccine uptake (Bardenheier et al., 2006; Chi & Neuzil, 2004; Nowalk et 
al., 2004; Winston et al., 2006). It has also been reported that to receive the influenza 
vaccination, a provider recommendation about the vaccination was more likely to help 
with the vaccine uptake (Bardenheier et al., 2006; Chi & Neuzil, 2004; Lindley et al., 
2006; Wray et al., 2007). Some earlier studies have reported that family members’ 
recommendations were considered another reason for effective vaccine uptake (Nowalk 
et al., 2004; Zimmerman, Nowalk, et al., 2003; Zimmerman, Santibanez, et al., 2003). 
Earlier studies have also reported that these recommendations were effective in the 
influenza vaccine uptake (Mayo & Cobler, 2004). Physician and other clinicians’ 
recommendation and reminder systems for the influenza vaccine are associated with 
increases in vaccination rates significantly (Anderson, Goeree, Sebaldt, Donald, Lohfeld, 
et al., 2008). Such practice strategies can be cost-effective in preventing the 
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complications of influenza. Studies have reported that that many physicians and other 
healthcare providers do not routinely recommend influenza vaccines to their adult 
patients, despite evidence showing that the clear majority of patients will receive 
vaccinations if their health-care provider recommends them (Johnson, Nichol, & 
Lipczynski, 2008; Schwartz, Neale, Northrup, Monsur et al., 2006).  
Self-Efficacy to Influenza Immunization 
Self-efficacy is the confidence and the ability to make successful informed 
decisions Glanz, Rimer & Lewis, 2002). Fewer studies related to influenza vaccination 
examined the role of self-efficacy, perhaps because vaccination is a simple, time-limited 
behavior that does not require lifestyle adjustments or changes to complex health 
behaviors such as adhering to an exercise program or eating a healthier diet (Brewer & 
Rimer, 2008; Champion & Skinner, 2008). Earlier studies have reported that in the case 
of influenza vaccination, self-efficacy does not appear to be an important determinant of 
influenza vaccination among adults (Chapman & Coups, 1999). Clinicians can 
incorporate the construct of self-efficacy in helping their patients to build their 
confidence by providing training, guidance and positive reinforcement about the 
influenza vaccine (Glanz, Rimer & Lewis, 2002). Such confidence can be evaluated by 
discussion with patients about their experience with prior influenza vaccine, which may 
build confidence, decrease doubts, and help to eliminate barriers. Clinicians can also 
incorporate discussion in the form of a brief anonymous survey after a skill building 
session to elicit questions or concerns that may remain on the patient’s mind (Glanz, 
Rimer & Lewis, 2002).  
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Patient education and recommendation for the influenza vaccination by clinicians 
can address any doubts and misinformation patients may have. Zimmerman et al. (2003) 
reported that patient education and recommendation for the influenza vaccination by 
healthcare providers can help to increase the likelihood of patients receiving the vaccines 
by eliminating misconceptions, vaccine-related concerns and myths. Research have found 
that healthcare providers can increase vaccination rates among the older adults by 
critically addressing patients’ concerns about the possible side effects and interaction 
with other medication they may be taking to manage chronic illnesses (Wray, Jupka, 
Ross et al., 2007; Wray, Jupka, Ross et al., 2009). 
Demographic Mediating Factors to Influenza Immunization 
Demographic mediating factors refer to modifying variables such as age, sex, 
race, ethnicity, and education that may interfere influenza vaccine uptake indirectly by 
affecting perceived susceptibility, benefits, barriers, cues to action and self-efficacy 
(Glanz, Marcus Lewis, & Rimer, 1997; Glanz, Rimer, Viswanath (2008). Influenza is a 
preventable health problem affecting the older adults that can lead to serious medical 
complications (CDC, 2014). Many individuals do not embrace the health benefits 
associated with influenza vaccination and they continue to doubt the vaccine the vaccine 
safety which can contribute to the hesitancy of vaccine uptake (Yaqub et al., 2014). For 
people to make changes in their health beliefs about the influenza vaccine, they must 
believe that the changes will benefit their health and that they can make such changes 
(Zimmerman, et al., 2003). By counseling older adult patients and acknowledging their 
fear and susceptibility to influenza can help them to make changes in their behavior, 
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which will motivate them to make informed decisions (Johnson, Nichol, Lipczynski, 
2008). Older adults are already aware that increased age and history of chronic diseases 
place them at increased risk for influenza and the related complications. There are also 
those who are not aware of their risk and there will be an increase need for health 
behavior change among this group. Individuals with different methods of learning might 
be influenced by different cues, such as television influenza vaccine commercials, flyers 
and posters with influenza vaccine messages, influenza vaccine campaign, advice from 
family and friends, education and reminders from healthcare providers, and their own 
personal reasons, such as a loved one who suffered with influenza or have already taken 
the influenza vaccine. Dexter, Teare, Dexter, Siriwarden, Read, (2012) reported that the 
independent factors associated with performance that predicted higher vaccination rate 
for at-risk patients which included clear leadership, effective communication about 
performance and methods used to identify and contact eligible patients were 
independently associated with significantly higher rates of flu vaccination. Banach, 
Ornstein, Factor, Soriano, 2012 reported that the association between social, demographic 
and health-related characteristics and influenza vaccine refusal among people ages 65 and 
over were positively associated with female gender, African American (Black) race, and 
living alone. Chiatti, Barbadoro, Lamura, Pennacchietti, et al 2011 surveyed a group of 
Italian to determine influenza vaccine uptake and reported that being unmarried and 
living in larger households were risk factors for lower immunization rates among elderly 
Italians.  
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Recency of Influenza Vaccine Uptake 
Recency refers to measurement of the most recent influenza vaccine uptake 
within one year or less (CDC, 2013). Influenza vaccine is required every year for two 
reasons: (1) the body’s immune response from vaccination declines over one year, so an 
annual vaccine is needed for optimal protection; and (2) the influenza viruses are 
constantly changing causing the formulation of the influenza vaccine to reviewed and 
updated each year based on the circulating viruses (CDC, 2011). Every year the influenza 
disease places many at risk older adults for influenza complications and hospitalizations 
(CDC, 2013). Studies have shown that recency of influenza vaccine uptake within one 
year or less has proven to be safe and effective in preventing influenza and its 
complication among the (CDC, older adults 2010). Studies have reported that there is an 
age-related decline in immune responses in the older adults causing a greater 
susceptibility to infection and reduced responses to vaccination (Skowronski, Tweed & 
Serres, 2008). Other studies have indicated that a low protective effect of the influenza 
vaccine suggest a decline in vaccine effectiveness in the older adults over time post 
vaccination therefore annual influenza immunization of high-risk populations against 
influenza remains the most important preventive method (Castilla, Martinez-Baz, 
Martinez-Artola et al., 2013) 
According the CDC (2013), antibodies against the influenza viruses begin to 
appear one to two weeks after receiving the influenza vaccine and last for several months, 
and sometimes even up to one year. Since the immune response to the influenza vaccine 
declines in a year or less and the influenza virus is constantly changing, the CDC (2013) 
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recommended that for optimal protection, the annual influenza vaccine is needed each 
year. Songa et al. (2010) compared long-term immunogenicity of influenza vaccine 
among older and younger adults during an interval period of 1, 6, and 12 months after 
vaccination. The findings indicated that neuroprotection rates at 1-month post-
vaccination ranged from 70.1% to 90.3% depending on the age group and influenza 
vaccine virus strain; at 6-months post-vaccination, seroprotection rates for all three 
strains had declined significantly in older adults (p <0.01). Low pre-vaccination HI titer 
(<1:40) and advanced age were associated with early decline of HI titers, falling below 
seroprotective levels around 6 months after vaccination (Songa et al., 2010) 
Frequency of Influenza Disease 
Frequency of Influenza disease refers to measurement of the most recent episode 
of influenza disease within one year or less (CDC, 2013). Influenza vaccine is one of the 
most recommended method of reducing influenza complication, hospitalization and death 
among the older adults CDC, 2013). The uptake of influenza vaccine uptake within a year 
or less can decrease the frequency of influenza disease among the older adults (CDC, 
2010). According to the CDC (2013), the efficacy of the influenza vaccine is measured 
by comparing the frequency of influenza illness among persons vaccinated and those who 
have not been vaccinated with the influenza vaccine. Studies have indicated that those 
who had received the influenza vaccine in a year or less had a decrease incidence in 
influenza and its complication. Although immune response to the influenza vaccine 
declines in a year or less the vaccine is still effective in preventing complications and 
death among older adults (CDC, 2013). It has been reported that the influenza vaccine is 
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50%–60% effective in preventing hospitalization and 80% effective in preventing death 
(CDC, 2012). A survey carried out in Genesee County, Michigan during the influenza 
outbreak from 1982–1983 to evaluate unvaccinated nursing home residents. Findings 
from this survey indicated that unvaccinated older adult residents were four times more 
likely to die than were vaccinated older adults’ residents (CDC, 2010). 
Literature Providing Differing Views 
The effectiveness of the influenza vaccine is a concern that is debatable among 
many researchers. Although the influenza vaccination provides some protection and may 
prevent complications due to pneumonia, hospitalizations, and death, the effectiveness is 
variable. Reports from a recent systematic review and meta-analysis of influenza vaccine 
protection identified that there was 59% effectiveness of the trivalent influenza vaccine in 
adults aged 18 to 65 years and a higher effectiveness (83%) of the live-attenuated vaccine 
(LAIV) in children (Osterholm, Kelley, Sommer, & Belongia, 2012). Another study 
reported that influenza vaccination was associated with a 27% reduction in the risk of 
hospitalization for pneumonia or influenza and a 48% reduction in the risk of death 
(Nichol, Nordin, Nelson, Mullooly & Hak, 2007). Simonsen et al. (2009) argued that 
although placebo-controlled randomized trials show influenza vaccine is effective in 
younger adults; few trials have included older adults, and especially those who are at 
least 70 years, which accounts for three-quarters of all influenza-related deaths. 
Literature on Methodology 
Many the literature reviewed were both qualitative and quantitative in nature and 
they investigated personal characteristics which were thought to be predictors of 
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influenza vaccine uptake, such as age, sex, comorbidity, educational level, income and 
specific area of residence (Dexter, Teare, Dexter, Siriwarden, Read, 2012). Several 
studies used telephone survey to identify predictors of and barriers to vaccine uptake 
(Böhmer et al., 2012; Banach, Ornstein, Factor, & Soriano, 2012; Johnson, Nichol, & 
Lipczynski, 2008). Many quantitative studies used the Likert scales, open ended and 
closed ended questions, and self- report for vaccination status to measure constructs for 
factors (Johnson et al., 2008; Santibanez et al., 2010). Coe, Gatewood et al. (2012) used 
anonymous, self-administered questionnaire based upon the HBM to assess participants’ 
perceptions of severity, risk, and susceptibility to the novel H1N1 influenza virus and/or 
vaccine. Other predictors identified were prior experience, concerns about the vaccine, 
perceived risk and advice and information from clinicians and caregivers (Johnson, 
Nichol, Lipczynski, 2008; Schwartz, Neale, Northrup, Monsur et al. 2006). However, 
since the main goal of this research is to use the HBM to identify the individuals’ 
perception of the influenza vaccine, studies that focused on the health beliefs, attitudes, 
perceptions and subjective experiences of older adults were most beneficial to this study 
(Chiatti, Barbadoro, Lamura, Pennacchietti, et al 2011; Müller, and Szucs, 2007; 
Raftopoulos, 2007; Gidengil, Parker, Zikmund-Fisher, 2011; Banach, Ornstein, Factor, 
Soriano, 2012).  
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Summary and Transition 
The literature reviews for this study introduced the background of the study, 
problem statement, its effect on the older adults, influenza virus and its complications 
among the elderly. The research review demonstrated the importance of 
recommendations and guidelines for influenza control among the older adults, guidelines 
and recommendation for management of influenza among the older adults, barriers that 
have been identified to explain why the older adults may not receive the seasonal 
influenza vaccine. Some inconsistencies in the recommendations for influenza 
management among the older adults were identified, the specific perceptions regarding 
diagnosing and treating seasonal influenza has only been briefly explained. This study 
contributes to gaps in the literature by addressing older adults’ perceptions, beliefs and 
adherence to influenza vaccine recommendations and the importance of clinician/ 
communication about the seasonal influenza vaccine. Most clinicians are in the position 
to have a major influence on their patients since they have developed a trusting 
relationship. Establishing better communication and reminders may assist in increasing 
influenza vaccine uptake by the older adults. With the increasing healthcare costs related 
to influenza epidemic and its complications among the older adults, and the increasing 
number of older adults in our society warrant there is an urgent need for this research. 
The HBM is used in this study as a theoretical guide for predicting influenza vaccine 
uptake among the older adults and therefore guides this research methodology. The 
rationale for this study was developed to identify significance of the perception of 
participants involved and explain how the research plans were carried out. The study’s 
49 
 
 
conceptual background and methodology were defined based on the constructs of the 
HBM. The design for this study was chosen based on existing literature about influenza 
vaccine uptake among older adults.  
Chapter 3 begins with a brief discussion of the steps used in the literature review. 
It describes in detail the: study design, sample, setting, data collection procedures, and 
data analysis. Protection of human participants and limitations of the study are also 
addressed.   
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Chapter 3: Research Method 
Introduction 
The purpose of this study was to identify perceived factors that may be associated 
with poor influenza vaccination uptake among older adults. In this quantitative study, I 
developed a new scale to measure the HBM constructs associated with influenza vaccine. 
In this chapter, the study design, sample, setting, data collection procedures, and data 
analysis are discussed. Protection of human participants and limitations of the study are 
also addressed.  
Research Design and Approach 
This was a descriptive study using a quantitative cross-sectional design where 
self-administered questionnaires were used. In this study, I identified the correlation 
between patients’ perception of the severity of the influenza epidemic and the importance 
of the influenza vaccine uptake. Based on the nature of this study, a cross-sectional 
approach was appropriate because the intention of this study was to determine whether 
there is a relationship between older adults’ perceptions of influenza epidemic and the 
importance of the annual uptake of the influenza vaccine. 
In this study, I explored older adult perceptions of the influenza epidemic and 
how these perceptions guide the likelihood of obtaining of the seasonal influenza vaccine 
as well as the effects of contribution of providers’ communication in helping to raise the 
awareness about the influenza vaccine. The questionnaire was designed to provide a 
quantitative display of the participants’ perception that guides their behaviors in 
obtaining the seasonal influenza vaccine.  
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The independent variables are the HBM constructs: perceived susceptibility, 
perceived severity, perceived barriers, perceived benefits, perceived cues to action, 
perceived self- efficacy, and mediating demographic characteristics including gender, 
age, educational level, annual income, and place of residence. The dependent variables 
were recency of influenza vaccine uptake and frequency of influenza disease within 1 
year or less, which represented the efficacy and effectiveness of influenza vaccination for 
possible outcome measures, including the prevention of influenza infection.  
Setting and Sample 
The purpose of this section is to discuss the setting, the sample selection, sample 
size calculation and rationale, and eligibility criteria. The study took place in three senior 
citizens center in the suburban areas of Brooklyn, New York. The area is populated with 
approximately 40% African Americans, 20% Hispanics, 10% Asians, and 30% European 
American (Whites).  
The sample consisted of 147 participants from three senior citizen centers 
suburban area of Brooklyn, New York. A convenience sample was used since random 
sampling and availability of individual respondents may not be feasible. Older adult 
clients who were members of the selected senior centers and agreed to participate in the 
study were selected until the required sample of 147 respondents was obtained. Inclusion 
criteria consisted of (a) men and women, (b) ages 65 years and older, (c) English 
speaking, (d) oriented to person, time, and place, (e) members of the selected senior 
citizen centers, and (f) able to understand the English language. I prescreened the 
participants who responded to the request to participate in the study for eligibility prior to 
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data collection. Prescreening consisted of explaining to each participant about the nature 
of the study and by signing the consent form that they were agreeing to participate in the 
study. Participants were asked again if they still wished to continue in the study; once 
they agreed to participate in the study, they were interviewed. I then set up the participant 
to begin completing the questionnaires/surveys.  
Justification for Choice of Methodology 
A quantitative cross-sectional study design was used to measure the factors and 
provide descriptive statistical findings on a selected population of elderly who attended 
three senior centers in Brooklyn, New York. Another reason for selecting this design was 
to better explain the hypotheses and determine the correlation between the independent 
and dependent variables. According to Creswell (2009), quantitative strategies quantify 
relationships between variables and emphasize mathematical measurement, using 
statistical analysis. The survey approach used a 33-item group administered questionnaire 
where participants answered the questions using a 5-point Likert scale (1-Strongly 
Disagree to 5-Strongly Agree) and provided answers to open ended and closed ended 
questions concerning their perception of influenza vaccine uptake.  
Instrumentation and Materials 
Development of a New Survey 
The review of the literature did not identify surveys measuring perceptions of 
older adults concerning using the HBM, but it was important for me to identify the 
perceptions of older adults based on the HBM. The closest instrument prototype was 
Champion's Health Belief Scales for Mammography Screening, 1997. The newly created 
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survey instrument was developed using information from the literature on previous 
research studies that have used the HBM. The questions were initially created after 
reviewing other studies that investigated many topics using the HBM, concerning the 
perception of older adults’ perception about vaccine uptake. The HBM was used to 
evaluate older adults’ perception of influenza disease and vaccine uptake questions that 
were categorized based on the six constructs of the HBM: perceived susceptibility, 
perceived benefit, and perceived seriousness, perceived barriers, cues to action, and self-
efficacy, and demographic mediating factors. Recency of influenza vaccine uptake and 
frequency of influenza infection within 1 year or less were included in the instrument 
questionnaire. The survey instrument consisted of a 33-item questionnaire. A total of 25 
questions were based upon the constructs of the HBM, six questions were based on 
demographic mediating factors, one question was based on the frequency of influenza 
disease, and one question was based on recency of influenza vaccine uptake. Questions 1 
through 4 were developed to assess the subject's perceived severity to seasonal influenza. 
Questions 5 through 7 were developed to assess perceived susceptibility of seasonal 
influenza. Questions 8 through 14 addressed perceived clinical barriers to seasonal 
influenza vaccination. Questions 15 through 17 addressed perceived benefits of the 
influenza vaccine. Questions 18 to 21 addressed cues to action concerning a reminder 
from clinicians and family members as well as information from posters, books, or 
television. Question 22 through 25 addressed perceived self-efficacy concerning 
confidence in obtaining the seasonal influenza vaccine. Five questions concerning 
demographics mediating factors, age, gender, race/ethnicity, and estimated annual 
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income, were also used in the survey. Also, two questions concerning recency of 
influenza vaccine uptake and frequency of influenza disease were assessed. Each section 
of the questionnaire used a 5-point Likert scaled response set (1--strongly disagree, 2–
disagree, 3--neither agree nor disagree, 4–agree, 5--strongly agree) except for frequency 
of the influenza disease that was measured using 0 to 4 or more times, and recency of 
influenza vaccine uptake was measured using never to most recent. The survey did not 
contain any identifiable patient information.  
Validity and Reliability 
Since this was a newly constructed scale, there were concerns about the 
methodological issues of validity and reliability of the scale. To address the 
methodological issues of validity and reliability of the scale, an expert review panel was 
asked to assess and revise the survey prior to official data collection. To improve the 
instrument validity, all feedback from the expert panel concerning the instrument was 
discussed among the group and corrections were made.   
The reliability of the instrument was determined by measuring internal 
consistency (Cronbach’s alpha) and a test-retest reliability (correlation coefficient). Test-
retest reliability was tested by administering identical versions of the scale items at two 
different occasions under the same conditions after 2 weeks. The degrees of similarity 
between the two test-retest reliability measurements were determined by computing a 
correlation coefficient. For the reliability analysis, 50 older adult volunteer participants 
were asked to retake the survey 2 weeks after the first administration.   
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Expert Panel Review Process 
The expert panel who reviewed the survey questionnaire for validity and 
reliability were selected using the criteria based on education, profession, and experience 
with research. Three medical doctors and three nurse practitioners were selected to 
participate in the expert panel review. The expert panel provided timely feedback, and the 
survey was revised based on the consensus of the group. An overview of the purpose of 
the study and the constructs of the HBM and mediating factors were presented to group 
members to ensure that all members were familiar with the aim of the instrument's 
development. The group was asked to evaluate the survey questions for face validity. 
Group members were given a copy of a draft questionnaire. The Expert Review Panel 
form (Appendix D) was provided to each member to review with a section for their 
written editorial comments. Changes to the survey were based on the expert panel 
suggestions, and they were asked to review the revised survey (Appendix D). The 
timeframe for this process was 30 days. The Expert Review Panel members were 
instructed to be candid and provide comments that truly reflected how they felt. A journal 
was kept to record individual member input. The instrument was refined during each 
meeting until a consensus was reached on the content of the instrument and the validity 
of the items. 
Final Survey Instrument 
The finalized survey instrument included 33 structured questions (Appendix D). 
A total of 25 questions were based upon the constructs of the HBM and demographic 
mediating factors. Four questions assessed perceived severity to seasonal influenza. 
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Three questions assessed perceived susceptibility of seasonal influenza. Seven questions 
addressed perceived clinical barriers to seasonal influenza vaccination. Three questions 
addressed perceived benefits of the influenza vaccine. Four questions addressed cues to 
action concerning reminders from clinicians and family members and information from 
posters, books, or television. Four questions addressed perceived self-efficacy concerning 
confidence in obtaining the seasonal influenza vaccine. Five questions concerning 
demographics mediating factors such as age, gender, race/ethnicity, and estimated annual 
income, was used for the survey. In addition, two questions concerning recency of 
influenza vaccine uptake and frequency of influenza disease were assessed. Each section 
of the questionnaire used a 5-point Likert scaled response (1--strongly disagree, 2–
disagree, 3--neither agree nor disagree, 4–agree, 5--strongly agree) except for frequency 
of the influenza disease that was measured using 0 to 4 or more times and recency of 
influenza vaccine uptake that was measured using never to most recent. The survey did 
not contain any identifiable patient information.  
HBM Constructs and Survey Items 
Perceived susceptibility was based on the participants’ subjective perception of 
the risk of acquiring influenza and the variation of the person's feelings of personal 
vulnerability to influenza infection. Perceived severity assessed the participants’ feelings 
on the seriousness of contracting the influenza infection and whether if left untreated, 
there is a possibility of related complications. The extent to which feelings about 
influenza severity may affect a person to consider the medical consequences varies, such 
as hospitalization from complications or death, and social impact on family life and other 
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social relationships. Perceived benefits assessed the participants’ perception of the 
effectiveness of the influenza vaccine to reduce the threat of influenza infection. The 
course of action the participant would take to prevent influenza infection disease was in 
consideration and evaluation of both perceived susceptibility and perceived benefit, such 
that the person would accept the recommended health action if it was beneficial. 
Perceived barriers assessed participants’ perceived beliefs about the obstacles to the 
uptake of the influenza vaccine. There is wide variation in perceived barriers that leads to 
a cost/benefit analysis; therefore, the person may weigh the effectiveness of the influenza 
vaccine against the perceptions that it may be expensive or dangerous because of side 
effects, causes unpleasantness such as pain, be time-consuming, or be inconvenient. Cue 
to action assessed the stimulus needed to trigger the decision-making process to accept a 
recommended influenza vaccine. These cues can be advice from healthcare practitioners, 
illness of a family member, a newspaper article, and television commercials. Self-
efficacy assessed the level of participants’ confidence in their ability to successfully 
receive the influenza vaccine. Demographics mediating factors were age, gender, 
race/ethnicity, estimated annual income, and place of residence. The dependent variables 
were the frequency of influenza disease within 1 year or less and recency of influenza 
vaccine uptake within 1 year or less. 
Analytical Process of Correlating Variables 
Each research question was answered by testing the corresponding hypotheses. 
The variables used for hypothesis testing included the independent variables, which were 
the perceptions of older adults’ beliefs about the influenza disease and influenza vaccine 
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uptake as a preventive method, and the dependent variables, which were the frequency of 
influenza disease within 1 year or less and recency of influenza vaccine uptake within 1 
year or less. 
Scoring of Independent and Dependent Variables 
Independent variable perceived susceptibility was scored 1 to 5 on a subscale of 
four items with an ordinal range of 4 to 20. Independent variable perceived severity was 
scored 1 to 5 by a subscale of three items with an ordinal range of 3 to 15. Independent 
variable perceived barrier was scored 1 to 5 by a subscale of six items with an ordinal 
range of 3 to 15. Independent variable perceived benefit was scored 1 to 5 by a subscale 
of three items with an ordinal range of 3 to 15. Independent variable perceived cues to 
action was scored 1 to 5 by a subscale of four items with an ordinal range of 4 to 20. 
Independent variable perceived self-efficacy was scored 1 to 5 by a scale of four items 
with an ordinal range of 4 to 20. The six mediating demographic variables are presented 
in Table 1, including gender, age, race, educational attainment, income, and place of 
residence.  
The dependent variables for this study are frequency of influenza disease and 
recency of influenza vaccine. The measures of frequency of influenza disease and 
recency of influenza vaccine consisted of derived binomial distribution (1 = infection ≤ 1 
year; 0 = everyone else). The responses to the questions were indicated as numerical 
values with increasing numbers indicating increased agreement regarding the variable. 
Tables 1, 2, and 3 illustrate the type of variables, description of the level of agreement 
each survey questions, type of statistical analysis, and values of the response categories.   
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Table 1 
Independent Variables for Hypotheses Testing 
Variable Description Type Values 
Perceived 
Susceptibility 
 
 
 
 
Perceived 
Severity 
 
 
 
 
 
Perceived 
Benefits 
 
 
 
 
 
Perceived 
Barriers 
 
 
 
 
 
Cues to 
Action 
 
 
 
 
 
 
Self-Efficacy 
 
Likelihood of getting 
influenza disease 
 
 
 
 
 
Impacted if they were 
affected by influenza 
disease 
 
 
 
 
The benefits and effective 
the influenza vaccine 
 
 
 
 
The difficulties encounter in 
taking the obtaining the 
influenza vaccine 
 
 
 
 
The prompts that are needed 
to move the person into the 
state where they are ready 
to take the influenza 
vaccine. 
 
 
The confidence and belief in 
their own ability to take the 
influenza vaccine 
 
Logistic Regression 
Odds Ratios and 95% 
Confidence Intervals 
 
 
 
 
Logistic Regression 
Odds Ratios and 95% 
Confidence Intervals 
 
 
 
 
Logistic Regression 
Odds Ratios and 95% 
Confidence Intervals 
 
 
 
 
Logistic Regression 
Odds Ratios and 95% 
Confidence Intervals 
 
 
 
 
Logistic Regression 
Odds Ratios and 95% 
Confidence Intervals 
 
 
 
 
Logistic Regression 
Odds Ratios and 95% 
Confidence Intervals 
 
 
1=Strongly Disagree 
2=Disagree  
3=Neither Agree nor 
Disagree  
4=Agree 
5=Strongly Agree 
 
1=Strongly Disagree 
2=Disagree  
3=Neither Agree nor 
Disagree  
4=Agree 
5=Strongly Agree 
 
1=Strongly Disagree 
2=Disagree  
3=Neither Agree nor 
Disagree  
4=Agree 
5=Strongly Agree 
 
1=Strongly Disagree 
2=Disagree  
3=Neither Agree nor 
Disagree  
4=Agree 
5=Strongly Agree 
 
1=Strongly Disagree 
2=Disagree  
3=Neither Agree nor 
Disagree  
4=Agree 
5=Strongly Agree 
 
1=Strongly Disagree 
2=Disagree  
3=Neither Agree nor 
Disagree  
4=Agree 
5=Strongly Agree 
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Table 2 
Dependent Variables for Hypotheses Testing 
Variable Description Type Values 
Frequency Number of times had 
influenza in past year 
Logistic Regression 
Binomial distribution 
1=# infections ≤ 1 
year;  
0=everyone else 
 
0=0 times 
1=1 time 
2=2 times 
3=3 times  
4=4 or more times 
 
Recency 
 
Last time the influenza 
vaccine was received 
Logistic Regression 
Binomial distribution; 
1=within the year; 
0=everyone else 
1=Never  
2=> 3 years 
3=2-3 years ago 
4=Last year 
5=This year 
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Table 3 
Demographic Variables for Descriptive Analysis and Hypotheses Testing 
Variable Type Values 
Gender 
 
 
Age 
 
 
 
Race/Ethnicity 
 
 
 
 
 
Education 
 
 
 
 
 
 
Place or residence 
 
 
 
 
Income 
Nominal 
 
 
Ordinal 
 
 
 
Nominal 
 
 
 
 
 
Ordinal 
 
 
 
 
 
 
Nominal 
 
 
 
 
Ordinal 
1=Male 
2=Female 
 
1=65-69 
2=70-74 
3=75 or greater 
 
1=European Americans (Whites) 
2=African American (Black) 
3=Hispanic  
4=Asians 
5=Other, specify: _________ 
 
1=Grade School  
2=Some High School  
3=High School Diploma/GED 
4=Some College  
5=Bachelor Degree  
5=Graduate/Professional Degree 
 
1=Family house 
2=Own house alone 
3=Residence for senior citizens 
4=Other, specify 
 
1=Under $10,000  
2=$10,000 - $19,999 
3=$20,000 - $29,999 
4=$30,000 - $39,999 
5=$40,000 - $49,999 
6=$50,000 - $59,999 
7=$60,000 or above. 
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Protection of Human Participants 
Walden IRB Approval 
Each senior center was contacted and approvals by the directors were acquired 
before carrying out the survey. The data collection began after IRB approval was 
obtained on February 3, 2015 (IRB # 02-04-15-0145747). The participants in the study 
were older adults, aged 65 and older and fall under the vulnerable category of human 
participant protection requiring a full board review and approval. The IRB at Walden 
determined the appropriate human rights protection of the participants. Maintaining 
confidentiality and privacy of participants and securing informed consent were important 
to maintain the integrity of this study. Each participant received a consent form at the 
beginning of the survey describing the study and explaining that participation was 
voluntary. Those participants who voluntarily agreed to participate in the survey 
proceeded with the consent. Participants only used initials of first and last names on the 
authorization form before screening was done. All research data will be stored for 5 years 
and will be destroyed after such time. 
Screening for Dementia 
The prevalence of dementia increases from less than 1% among people 65 years 
of age or younger, to an estimated 3–11% among those 65-84 years old, and to around 
33% of those aged 85 years and older (Boutsani, et al., 2003; Lobo, et al. 2000; Rocca, et 
al. 1990; Skoog, et al. 1993). Studies have also reported that cognitive impairment, not 
dementia (CIND), is even more common, with an estimated prevalence of around 17% in 
people 65 years and older (Graham, Rockwood, Beattie, et al. 2003). To maintain the 
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integrity of this study the General Practitioner Assessment of Cognition (GPCOG) 
(Brodaty et al., 2002) was used as a brief four to five minutes screening test for cognitive 
impairment of all participants who voluntarily agreed to participate in the study. Prior to 
the GPCOG-screening participants signed an authorization form. The participants’ 
GPCOG screening evaluation contained the following cognitive test items: time 
orientation, clock drawing, reporting a recent event and a word recall task. A GPCOG-
participant score of 9 indicates no cognitive impairment and was used as an inclusive 
criterion for the study. If a GPCOG-participant score is between 5 and 8, the GPCOG-
informant interview was administered but these participants were not included in the 
study. During the informant interview the informant was asked about the older adults’ 
memory of recent conversations, misplacing objects, word finding difficulties, ability to 
manage money, ability to manage medication, and need for travel assistance. A GPCOG-
participant score of 4 or lower or a GPCOG-informant section score of 3 or lower 
suggests cognitive impairment (Brodaty et al., 2002). Each older adult participant who 
received the cognitive screening score of nine or more and voluntary agreed to participate 
in the study received a consent form and consent explanation sheet that described the 
study and explained that participation or the completion of the survey was voluntary.  
Anonymity 
Participant anonymity was achieved through using initials of first and last names 
in the consent form. The raw data were managed only by me and no participant contact 
information was available about this survey. Before proceeding with the survey each 
participant was informed that they have the right to stop the survey at any time if they 
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had any doubts. Since this research was not an invasive procedure there was no 
foreseeable harm to the participants in this study. Although the participants may not have 
personally benefited from this study, the study may provide valuable information for 
improvement in influenza vaccine uptake among the older adults.  
Test-Retest Participation 
All participants of the test-retest component of the study were asked to volunteer 
to take the survey two times, at the initial meeting and again two weeks later. If 
participants agreed, they checked “yes” on the question and enter their e-mail address. 
The e-mail was used to contact those participants two weeks later. The purpose of the 
GPCOG and the reason for doing the screening were explained to all participants who 
volunteered to participate in the GPCOG.  
Data Collection 
The survey was conducted at each of the three sites using the same method until a 
sample of 147 participants was obtained. Data was collected from May through July, 
2015. The survey took about 30 to 45 minutes to complete. I introduced myself to the 
prospective participant who volunteered to participate in the study and explained the 
purpose of the survey, how the survey would be distributed, the steps participants would 
take to complete the survey, the screening and consent processes, privacy and 
confidentially, the research variables, and data management. Participants were asked to 
answer survey questions in the same order as the items were printed. Extra care was taken 
during the data collection phase to ensure completeness of self-report and prevention of 
the occurrence of missing data. Before surveys were collected, the questionnaire was 
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examined for completeness and accuracy, and participants were asked to complete any 
missing questions.  
Statistical Analyses 
Data were entered directly into Microsoft Excel using keystrokes. Each entry was 
rechecked to prevent and identify data entry errors. Data were imported from Excel to 
SPSS (Statistical Product and Service Solutions) version 21. Range and frequency checks 
were used to ensure that none of the variables were outside the range of possible values. 
Data collected from the survey were tabulated for analysis using SPSS to identify 
frequencies, and correlation coefficients. The data related to each hypothesis are 
presented separately and analyzed as follows: 
Research Question 1. Is there a significant relationship between older adults 
‘perceived susceptibility to the seasonal influenza and frequency and recency of vaccine? 
H10: There is no significant relationship between older adults perceived 
susceptibility to the seasonal influenza and frequency and recency of vaccine.  
H1A: There is a significant relationship between older adults perceived 
susceptibility to the seasonal influenza and frequency and recency of vaccine. 
Statistical Plan: Independent Variable = Perceived susceptibility; Dependent 
Variables = Frequency of influenza vaccine uptake and Recency of influenza vaccine. 
Statistical analysis was ordinal logistic regression used on multiple independent variables 
to predict influenza disease, recency of influenza vaccine uptake, and frequency of 
influenza disease based on older adults’ perceived susceptibility. Null hypothesis was 
rejected if p <.05.  
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Research Question 2. Is there a significant relationship between older adults 
perceived severity to seasonal influenza based on CDC influenza guidelines? 
H20: There is no significant relationship between older adults perceived severity 
to seasonal influenza based on CDC influenza guidelines.  
H2A: There is a significant relationship between older adults perceived severity 
to seasonal influenza based on CDC influenza guidelines.  
Statistical Plan: Independent Variable = Perceived severity; Dependent Variables 
= Frequency of influenza vaccine uptake and recency of influenza vaccine. Statistical 
analysis was ordinal logistic regression analysis used on multiple independent variables 
to predict influenza disease, influenza vaccine uptake, frequency and recency of influenza 
vaccine based on older adults’ perceived severity. Null hypothesis was rejected if p <.05. 
Research Question 3. Is there a significant relationship between older adults’ 
perceived benefits and the positive consequences of the annual seasonal influenza 
vaccine uptake? 
H30: There is no significant relationship between older adults’ perceived benefits 
and the positive consequences of the annual seasonal influenza vaccine uptake.  
H3A: There is a significant relationship between older adults’ perceived benefits 
and the positive consequences of obtaining the annual seasonal influenza vaccine.  
Statistical Plan: Independent Variable = Perceived benefits; Dependent Variables 
= Frequency of influenza vaccine uptake and recency of influenza vaccine. Statistical 
analysis was ordinal logistic regression analysis used on multiple independent variables 
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to predict influenza disease, influenza vaccine uptake, and recency of influenza vaccine 
based on older adults’ perceived benefits. Null hypothesis was rejected if p <.05.  
Research Question 4. Is there a significant relationship between older adults’ 
perceived barriers and discouragement concerning the uptake of the seasonal influenza 
vaccine?  
H40: There no significant relationship between older adults perceived barriers and 
discouragement concerning the uptake of the seasonal influenza vaccine.  
H4A: There is a significant relationship between older adults’ perceived barriers 
and discouragement concerning the uptake seasonal influenza vaccine.  
Statistical Plan: Independent Variable = Perceived barriers; Dependent Variables 
= Frequency of influenza vaccine uptake and recency of influenza vaccine. Statistical 
analysis was ordinal logistic regression analysis used on multiple independent variables 
to predict influenza disease, influenza vaccine uptake, and recency of influenza vaccine 
based on older adults’ perceived barriers. Null hypothesis was rejected if p <.05.  
Research Question 5. Is there a significant relationship between older adults’ 
perceived cues to action and health care providers’ persuasive communications about 
seasonal influenza vaccine?  
H50: There is no significant relationship between older adults’ perceived cues to 
action and health care providers’ persuasive communications about seasonal influenza 
vaccine.  
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H5A: There is a significant relationship between older adults’ perceived cues to 
action and health care providers’ persuasive communications about seasonal influenza 
vaccine.  
Statistical Plan: Independent Variable = Perceived cues to action; Dependent 
Variables = Frequency of influenza vaccine uptake and recency of influenza vaccine. 
Statistical analysis was ordinal logistic regression analysis used on multiple independent 
variables to predict influenza disease, influenza vaccine uptake, and recency of influenza 
vaccine based on older adults perceived cues to action. Null hypothesis was rejected if p 
<.05.  
Research Question 6. Is there a significant relationship between older adults’ 
perceived self-efficacy and the ability to successfully obtaining the seasonal influenza 
vaccine?  
H60: There is no significant relationship between older adults’ perceived self-
efficacy and the ability to successfully obtaining the seasonal influenza vaccine.  
H6A: There is a significant relationship between older adults’ perceived self-
efficacy and the ability to successfully obtaining the seasonal influenza vaccine.  
Statistical Plan: Independent Variable = Perceived self-efficacy; Dependent 
Variables = Frequency of influenza vaccine uptake and recency of influenza vaccine. 
Statistical analysis was ordinal logistic regression analysis used on multiple independent 
variables to predict influenza disease, influenza vaccine uptake, and recency of influenza 
vaccine based on older adults’ perceived self-efficacy. Null hypothesis was rejected if p 
<.05.  
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Research Question 7. Is there a significant relationship between full HBM 
constructs plus mediating demographic factors such as age, gender, ethnicity, occupation, 
and older adults’ perceptions of the seasonal influenza vaccine? 
H70: There is no significant relationship between full HBM constructs plus 
mediating demographic factors such as age, gender, ethnicity, occupation, and older 
adults’ perceptions of the seasonal influenza vaccine.  
H7A: There is a significant relationship between full HBM constructs plus 
mediating demographic factors such as such as age, gender, ethnicity, occupation, and the 
elderly perceptions of acceptance of the seasonal influenza vaccine.  
Statistical Plan: Independent Variable = HBM constructs and mediating 
demographic factors; Dependent Variables = Frequency of influenza vaccine uptake and 
recency of influenza vaccine. Statistical analysis was ordinal logistic regression analysis 
used on multiple independent variables to predict influenza disease, influenza vaccine 
uptake, and recency of influenza vaccine based on older adults’ perceptions and 
demographic factors. Null hypothesis was rejected if p <.05.  
Research Question 8. Is there significant relationship between influenza vaccine 
recency and influenza disease among older adults? 
H80: There is no significant relationship between influenza vaccine recency and 
influenza disease among older adults. 
H8A: There is a significant relationship between influenza vaccine recency and 
influenza disease among older adults. 
70 
 
 
Statistical Plan: Independent Variable = Perceived susceptibility; Dependent 
Variables = Frequency of influenza vaccine uptake and Recency of influenza vaccine. 
Statistical analysis was ordinal logistic regression analysis used on multiple independent 
variables to predict influenza disease, influenza vaccine uptake, and recency of influenza 
vaccine based on older adults’ perceived susceptibility. Null hypothesis was rejected if p 
<.05.  
Research Question 9. Is there a significant relationship between influenza 
disease frequency and influenza vaccine uptake among older adults? 
H90: There is no significant relationship between influenza disease frequency and 
influenza vaccine uptake among older adults. 
H9A: There is a significant relationship between influenza disease frequency and 
influenza vaccine uptake among older adults.  
Statistical Plan: Independent Variable = Perceived susceptibility; Dependent 
Variables = Frequency of influenza vaccine uptake and Recency of influenza vaccine. 
Statistical analysis was ordinal logistic regression analysis used on multiple independent 
variables to predict influenza disease frequency, influenza vaccine uptake, and recency of 
influenza vaccine based on older adults’ perceived susceptibility. Null hypothesis was 
rejected if p <.05.  
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Threats to Validity 
Threats to External Validity 
The study was carried out at three senior centers in Brooklyn, New York and 
these locations may not be representative of all older adults. The sample was purposive 
and nonprobabilistic. The study sought to test a newly developed instrument and provide 
information about influenza uptake among Brooklyn seniors. Since age played a major 
factor causing the effect of the influenza vaccine to vary from one individual to the other, 
then age differences between the sampled older adult participants and the general 
population would lead to a biased estimate of the average influenza vaccine effect in that 
population. In this study, such bias was corrected by a simple re-weighing procedure: The 
age-specific effect in the older adult subpopulation was computed using the average age 
distribution in the general population which gave an unbiased estimate of the average 
influenza vaccine treatment effect in the general population. 
Threats to Internal Validity 
Some elderly might misinterpret the instructions on how to complete the survey. 
The direction on how to complete the survey was read twice to each older adult and each 
older adult could ask for help or ask questions while completing the survey before 
proceeding to answer the survey questions. Completing the survey questionnaire took 30 
to 45 minutes and the survey was administered in the mornings before other activities to 
prevent shift in focus due to tiredness or fatigue. Participants were allowed extra time if 
they requested to complete answering the questions. 
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Dissemination of Findings 
The growing rate of influenza and its complications among older adults is a public 
health concern (CDC, 2013). Recent reports from the CDC, 2013-2014 indicate that the 
influenza hospitalization rates among persons 65 and older increased greatly while 80 
percent of cumulative influenza-associated deaths occurred among this age group. There 
is a direct request for better influenza surveillance to assist in controlling the impact of 
influenza and to identify vaccine improvement, which is important for influenza 
complication prevention among older adults (PAHO, WHO, 2013).  
The goal of health care professionals and policy makers is to reduce the rate of 
influenza among the older adults. The study results were shared with the New York State 
Department of Health and local health departments in Brooklyn, NY. The results of the 
study will be submitted for publication in peer-reviewed journals such as American 
Journal of Public Health and other nursing journals. In addition, the outcome of the study 
can contribute to the gap in literature about the importance of annual uptake of influenza 
vaccine as the main method of prevention of influenza disease and its complication 
among the older adults. 
Summary and Transition 
 The study design, sample, setting, data collection procedures, and data analyses 
were discussed in this chapter. Protection of human participants and limitations of the 
study were also addressed in this chapter. A quantitative cross-sectional design was used 
to identify the prevalence of seasonal influenza vaccine uptake among the older adults. 
The study made use of a convenience sample of older adults who attended the three 
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selected senior centers in Brooklyn, NY. Data were collected using a 33-item 
questionnaire based on the HMB concepts, demographic mediating factors, frequency of 
influenza disease, and recency of influenza uptake. 
The questionnaire consisted of items related to the six constructs of the HBM plus 
mediating demographic factors to identify the perception of the elderly concerning the 
seasonal influenza vaccine. In addition, frequency of influenza disease and recency of 
influenza vaccine uptake were evaluated. Understanding factors that influence influenza 
uptake among older adults, awareness can increase among primary care providers and 
other clinicians regarding the importance of routine influenza vaccine reminders and 
recommendations. Chapter 4 provides the results of the survey and statistical analysis of 
the final interview. 
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Chapter 4: Results 
Introduction 
The purpose of this study was to identify perceived factors that may be associated 
with poor influenza vaccination uptake among older adults. The HBM guided this study. 
This quantitative study was used to answer nine research questions to evaluate older adult 
perceptions of annual seasonal influenza vaccine and factors that may contribute to poor 
influenza vaccine uptake. A new instrument was developed, and test-retest reliability was 
analyzed among a small sample of older adult participants. A survey approach was used 
for the data collection. In this chapter, factor analysis to measure the newly created HBM 
constructs is described. Descriptive analysis illustrates the demographic characteristics of 
the sample participants. The examination of correlations of older adult perceived health 
beliefs, recency of influenza vaccine, and frequency of influenza disease are reviewed. In 
addition, logistic regression analyses performed to test the hypotheses are discussed 
between HBM model predictors of frequency and recency of influenza disease within the 
last years. 
Characteristics of Participants 
Participants who spoke and read English were recruited from the three senior 
centers using a convenience sample approach. Data were collected from May through 
July 2016. The survey took about 30 to 45 minutes to complete. The total number of 
participants who consented to the survey was 162, of which 15 were excluded from the 
analysis because they did not meet the research criteria due to cognitive impairment as 
evidenced by the inability to think clearly, concentrate, and recall new information. The 
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findings presented reflect a final sample of 147. Table 4 shows the demographic 
distribution of the participants, by gender, age, and race, highest level of education, 
annual income, and place of residence. Most the sample were female (74%) and between 
the ages of 65 to 70 (77%). Most the participants identified themselves as members of 
minority groups, including 40% African Americans, 28% Hispanics, 6% Asians, and 
26% European Americans. About a third of the sample had at least some college 
education, and 45% had a household income under $10,000. Most of the participants in 
the sample lived independently either alone in their own home (38.4%) or in senior 
citizen housing (33%).   
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Table 4 
Frequency of Demographic Characteristics of Participants (n=147) 
Variable Frequency Percent 
Gender 
   Male 
   Female 
38 
109 
25.8 
74.2 
 
Age 
   65 -70 
   70- 75 
   75 or greater 
113 
31 
3 
76.9 
21.1 
2.0 
 
Race 
   European Americans 
   African Americans 
   Hispanic 
   Asians 
 
38 
59 
31 
9 
25.9 
40.1 
27.9 
6.1 
 
Highest Education 
   Grade School 
   Some High School 
   High School Diploma/GED 
   Some College 
   Bachelor Degree and higher 
 
18 
29 
24 
16 
30 
 
12.1 
19.7 
16.3 
10.9 
20.4 
 
Annual Income 
   Under $10,000 
   $10,000 - $19,999 
   $20,000 - $29,999 
 
66 
59 
22 
 
44.9 
40.1 
15.0 
 
Type of Residence 
   Family house 
   Own house alone 
   Residence for senior citizens’ home 
 
43 
55 
49 
 
29.3 
38.4 
33.3 
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Pilot Test Results 
Reliability Test Retest Analysis  
The survey was administered twice to 50 older adult participants who volunteered 
to retake the survey 2 weeks after their initial survey. According to Trochim (2008), the 
test-retest reliability is used to assess the consistency of a measure at two different time 
periods. Paired-samples t tests were run on the different construct items susceptibility, 
seriousness, barriers, benefits, cues to action, and self-efficacy (see Tables 5, 6, 7, 8, 9, 
and 10). The comparison of the mean perceptions across the two-time periods (perceived 
seriousness, susceptibility, barriers, benefits, and cues to action) resulted in a probability 
greater than 0.05, indicating that there were no significant differences between the 
administration times. The lack of differences in the two test administration times 
indicated that the instrument was reliable and was adequate for the survey.  
Perceived Susceptibility 
The construct of perceived susceptibility is an individual’s perception about the 
chances of getting the influenza disease, a serious disease, which may later lead to the 
motivation to adopt the appropriate health behavior to decrease the risk of getting 
influenza. I tested the susceptibility construct with three items, using a 5-point Likert 
scale with response categories being strongly disagree to strongly agree and scored 1 to 
5, with 0 for missing answers. A factor analysis was computed with the three perceived 
susceptibility items that indicated that there were no significant differences between the 
two test administration times. Table 5 shows the paired-samples t test of test-retest 
reliability of perceived susceptibility.   
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Table 5 
Paired Samples t-test for Test-Retest Reliability of Perceived Susceptibility 
 
Scale items 
 
Test 1 
mean(SD) 
Test 2 
mean(SD) 
 
Correlations 
Mean 
differences 
 
p  
 
t 
If I get the 
seasonal 
influenza virus 
I will get sick. 
 
4.82(.440) 
 
 
 
4.70(.610) 
 
 
 
.472 
 
 
 
.094 
 
 
 
.292 
 
 
 
1.076 
 
 
If I get the 
seasonal 
influenza virus 
I will lose 
income. 
 
4.89(.349) 
 
 
 
 
 
4.84(.444) 
 
 
 
 
 
.387 
 
 
 
 
 
.119 
 
 
 
 
 
.099 
 
 
 
 
 
1.705 
 
 
If I get the 
seasonal 
influenza virus 
other members 
in my home 
will get sick. 
 
4.30(1.016) 
 
4.04 (1.00) 
 
 
.156 
 
 
 
.229 
 
 
 
.258 
 
 
 
1.156 
 
 
If I get the 
seasonal 
influenza virus 
I will die 
 
4.78(.439) 
 
 
4.68(.610) 
 
 
.460 
 
 
.092 
 
 
.293 
 
 
 
1.074 
 
 
 
Perceived Severity 
The construct of perceived severity refers to the participants’ perception about the 
seriousness of influenza disease and its prevention. The perceived threat of influenza 
disease among older adults is a serious health concern. I tested the 4-item perceived 
seriousness construct, using a 5-point Likert scale with response categories ranging from 
strongly disagree to strongly agree and scored 1 to 5, with “0“ for missing answers. 
Although some mean differences are negative as indicated, the correlations and p values 
showed reliability. Therefore, correlation between the test and retest administration times 
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were reliable. Table 6 shows the paired-samples t test of test-retest reliability between 
perceived seriousness and influenza vaccine 
Table 6 
 
Paired Samples t-test for Test-Retest Reliability of Perceived Severity 
 
Scales 
 
Test 1 
mean(SD) 
Test 2 
mean(SD) 
 
Correlations 
Mean 
differences 
p  t 
I am at risk for 
getting the 
seasonal 
influenza virus 
4.08(.930) 
 
 
4.06(.716) 
 
 
.773 
 
 
-.026 
 
 
.804 
 
 
-.256 
 
 
My family 
members are 
at risk for 
getting the 
seasonal 
influenza 
virus. 
4.27(.643) 
 
4.44(.546) 
 
.445 
 
-.207 
 
.040 
 
-2.150 
 
 
I feel 
knowledgeabl
e about my 
risk of getting 
the seasonal 
influenza 
virus. 
 
4.88(.392) 
 
4.79(.425) 
 
.046 
 
.086 
 
.184 
 
.185 
 
 
Perceived Benefit 
The construct of perceived benefit refers to participants’ perception about the 
safety and effectiveness of taking the influenza vaccine to reduce the risk of getting 
influenza disease and the related complications. I tested three perceived benefit items 
using a 5-point Likert scale with response categories being strongly disagree to strongly 
agree and scored 1 to 5, with 0 representing missing answers. This subscale was reliable 
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because as indicated there were no significant differences between the times of 
administration of the two tests. Table 7 displays the results of the paired-sample t test for 
each item in the benefit subscale, which shows the correlations and p values reliability.  
Table 7 
 
Paired-Samples t-test of Test-Retest Reliability of Perceived Benefits 
Scale items 
 
Test 1 
mean(SD) 
Test 2 
mean(SD) 
 
ρ 
Mean 
differences 
 
p  
 
t 
If I receive the 
seasonal 
influenza 
vaccine, I will 
not get sick 
from the 
seasonal 
influenza virus 
 
2.45(1.064) 
 
 
2.79(1.220) 
 
 
.396 
 
 
 
-.333 
 
 
 
.095 
 
 
 
-1.711 
 
 
 
If I receive the 
seasonal 
influenza 
vaccine it will 
prevent 
complications 
from the 
seasonal 
influenza 
disease 
 
2.88(1.064) 
 
 
2.57(.914) 
 
 
.623 
 
 
 
.310 
 
 
 
.026 
 
 
 
 
2.308 
 
 
 
Seasonal 
influenza 
vaccines are 
safe. 
 
2.45(.999) 
 
 
2.40(.862) 
 
 
.542 
 
 
 
.049 
 
 
 
.738 
 
 
 
.340 
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Perceived Barriers 
The construct of perceived barriers refers to participants’ opinion of what is 
stopping them from making the decision to get the influenza vaccine that can protect and 
prevent influenza disease. I tested the barriers construct with seven items using a 5-point 
Likert scale with response categories being strongly disagree to strongly agree and 
scored 1 to 5, with 0 representing missing answers. This subscale was reliable, as there 
were no significant differences between the two test administration times. Table 8 
displays the results of the paired-sample t test for each item in this benefit subscale. As 
noted below, some mean differences are negative, but the correlations and p values show 
reliability.   
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Table 8 
 
Paired-Samples t-test of Test-Retest Reliability of Perceived Barriers 
Scale items 
 
Test 1 
mean(SD) 
Test 2 
mean(SD) 
 
ρ 
Mean 
differences 
 
p  
 
T 
I will have side 
effects from the 
seasonal 
influenza 
vaccine. 
4.89(.349) 4.80(.408) .617 .068 .184 1.356 
I will get sick 
from the 
seasonal 
influenza 
vaccine. 
2.89(1.168) 
 
2.89(1.111) 
 
.693 
 
024 
 
.864 
 
.173 
 
I will die from 
the seasonal 
influenza 
vaccine. 
2.55(.987) 
 
2.68(1.162) 
 
.444 
 
-.070 
 
.691 
 
-.401 
 
The seasonal 
influenza 
vaccine will be 
painful. 
4.10(.749) 
 
4.00(.946) 
 
.639 
 
.049 
 
.675 
 
.423 
 
The seasonal 
influenza 
vaccine will be 
expensive. 
2.01(.782) 
 
2.06(.924) 
 
.620 
 
.000 
 
1.000 
 
 
It is 
inconvenient to 
get the seasonal 
influenza 
Vaccine 
1.80(.850) 
 
1.88(.762) 
 
 
 
.787 
 
.070 1.000 
 
 
 
.001 
 
 
 
There is a 
shortage of the 
seasonal 
influenza 
vaccine 
1.89(.931) 1.95(.740) .493 
 
.000 .600 
 
.536 
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Perceived Cues to Action 
Cues to action are the factors that trigger that are necessary for prompting 
engagement in the decision-making process to accept the recommended influenza 
vaccine. I tested the cues to action construct using a five point Likert scale with response 
categories being strongly disagree to strongly agree and scored 1-5 with 0 representing 
missing answers This subscale was reliable, as there were no significant differences. 
Table 9 below shows the paired-samples t-test of test-retest reliability of perceived cues 
to action about influenza vaccine.  
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Table 9 
 
Paired-Samples t-test of Test-Retest Reliability of Perceived Cues to Action 
Scale items 
 
Test 1 
mean(SD) 
Test 2 
mean(SD) 
 
ρ 
Mean 
differences 
 
p  
 
t 
I will take the 
seasonal 
influenza 
vaccine if my 
doctor or my 
nurse said it is 
important 
 
 
1.95(.812) 
 
 
 
1.98(.723) 
 
 
 
.197 
 
 
 
-.048 
 
 
 
.757 
 
 
 
-.315 
 
 
I will take the 
seasonal 
influenza 
vaccine if a 
family member 
or significant 
other said it is 
important 
 
 
2.65(1.160) 
 
 
 
2.60(1.204) 
 
 
.506 
 
.049 
 
.798 
 
.264 
I will take the 
seasonal 
influenza 
vaccine if I see a 
TV ad that said 
it is important 
 
 
2.04(.812) 
  
2.16(1.034) 
 
-.120 
 
.398 
 
-.870 
I will take the 
seasonal 
influenza 
vaccine if the 
interdisciplinary 
team at my 
clinic reminds 
me. 
 
4.18(1.059) 
 
 
4.30(.865) 
 
.643 
 
.359 
 
.262 
 
 
 
.674 
 
Perceived Self-Efficacy 
The perceived self-efficacy construct measures the participants’ perception and 
the competence to successfully take an action in seeking the influenza vaccine. In this 
85 
 
 
case the elderly who received information about the influenza vaccine from close friends 
and relative, the media or health care providers were motivated to receive the influenza 
vaccine. This increased the knowledge and confidence to obtain the influenza vaccine. I 
tested the four perceived self-efficacy subscales using a five point Likert scale with 
response categories being strongly disagree to strongly agree and scored 1-5 with 0 
representing missing answers. The correlation between the two test administration times 
shows reliability. Table 10 below shows the paired-samples t-test of test-retest reliability 
of perceived self-efficacy about influenza vaccine uptake. 
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Table 10 
 
Paired-Samples t-test of Test-Retest Reliability of Perceived Self-Efficacy 
Scale items 
 
Test 1 
mean(SD) 
Test 2 
mean(SD) 
 
ρ 
Mean 
differences 
 
p  
 
t 
I am confident 
that I can obtain 
the seasonal 
influenza vaccine 
 
3.72(.935) 
 
3.90(.901) 
 
.550 
 
-.199 
 
.165 
 
-1.434 
 
I am confident 
that my day to 
day performance 
will not be 
adversely 
impacted by 
taking the 
seasonal influenza 
vaccine 
 
3.70(.793) 
 
3.58(1.001) 
 
.485 
 
.124 
 
.406 
 
.844 
 
I am confident 
that the seasonal 
influenza vaccine 
I will take will 
not exposed me to 
any side effects or 
death 
 
4.10(.980) 
 
4.22(.858) 
 
.615 
 
-.144 
 
.268 
 
-1.190 
 
I am confident 
that seasonal 
influenza vaccine 
will help to 
prevent me from 
getting the 
seasonal influenza 
throughout the 
influenza season. 
3.20(1.135) 3.29(1.200) .178 -.170 .480 -.726 
 
 
 
To estimate test-retest reliability, I administered the same test to the same group 
of 50 elderly participants on two different occasions. The amount of time allowed 
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between measures was two weeks. Based on the results of the two tests the value of the 
correlation was considered satisfactory. The results therefore demonstrated that the items 
in the instrument have good test-retest reliability and moderate to good construct validity 
for all items. 
Factor Analysis 
An Exploratory Factor Analysis (EFA) was done using SPSS to measure the 
reliability of the constructs that reflected the perceived behavior of older adults related to 
influenza vaccine uptake (IBM, SPSS). The process used for conducting the EFA 
involved three stages: Extraction, Rotation and Interpretation (IBM, SPSS). During the 
extraction process I looked at the process of determining how many factors within the 
data set best explained the observed covariation matrix. The appropriate number of 
factors to extract was determined by Eigenvalues and Scree plot. Since I was interested in 
explaining as much variance in observed indicators with the fewest latent factors, I 
decided to retain only those latent factors with sufficiently high eigenvalues. All the 
factors that were retained had an eigenvalues value above 1.  
The other alternative method used was inspecting the scree plot to determine the 
appropriate number of factors to retain and to correctly consider the relative size of the 
eigenvalues rather than the absolute size. Rotation was done to maximize the factor 
loadings for the items that best measure their respective factor. The interpretation of the 
data was done by naming the factors to provide a meaningful understanding of the 
common feature among the relevant items. 
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Cronbach’s alpha was calculated to measure internal consistency to see how 
closely the set of items were related as a group. In addition to measuring internal 
consistency, Cronbach’s alpha was used to test items and the average inter-correlation 
among the items to provide evidence that the scale is appropriate. Table 10 below shows 
the Cronbach’s alpha coefficients. Since Cronbach’s alpha reliability coefficient normally 
range between 0 and 1, with 0.7 being acceptable, all constructs were retained. 
Table 10 
Cronbach’s Alpha Coefficients of Health Belief Model Subscales 
Health belief model 
Subscales 
Cronbach’s alpha 
coefficients based on 
standardized items 
 
Susceptibility 
 
Severity 
 
Benefits 
 
Barriers 
 
Cues to action 
 
Self-efficacy  
.810 
 
.710 
 
.875 
 
.729 
 
.802 
 
.836 
  
Source: Newly developed influenza vaccine uptake scale 
Assumptions 
It is assumed that the nonparametric tests measured the relationship between 
variables and the residuals are normally and independently distributed. Assumptions can 
be made that descriptive statistics appropriately characterized the sample. Assumptions 
were made prior to data analysis that the data were screened for linearity, 
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homoscedasticity, normality, and multicollinearity. It was assumed that based on the 
analyses result there was lack of collinearity among the independent variables. 
Assumptions were made during the planning phase of the study to generalize the sample 
and the sample was representative of the population of older adults who attended the 
three senior centers in Brooklyn, New York. Assumptions associated with factor analysis 
showed that the data were analyzed using descriptive statistics, factor analysis, ordinal 
regression and correlation coefficient. It can also be assumed that data was assessed for 
missing values and adequate sample size. The test retest paired-sample t-tests reliability 
assumes that consistency of assessment of the test remained stable across time. 
Assumptions indicated that each independent variable can be assigned to the dependent 
variables. In addition, it was assumed that ordinal logistic regression was adequate to 
analyze the hypotheses predictor variables. It was assumed that the dependent and 
independent variables had ordinal levels of measurement. Since the independent variables 
did not highly correlate to each other, it can be assumed that the ordinal logistic 
regression analyses were adequate and correct.  
Research Questions and Hypotheses 
Nine specific research questions were addressed in this study. The results of the 
statistical analyses are presented in this section. The ordinal logistic regression analyses 
were performed to test the best set of predictor variables based on constructs of the HBM 
to identify the outcomes of older adult influenza vaccine uptake frequency and recency. 
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My intention for this first research question was to determine if there was a 
significant relationship between older adult perceived susceptibility to seasonal influenza 
and frequency and recency of vaccine uptake. 
1. Is there a significant relationship between older adults ‘perceived susceptibility to the 
seasonal influenza and frequency and recency of vaccine? 
H10: There is no significant relationship between older adults’ perceived 
susceptibility to the seasonal influenza and frequency and recency of vaccine. 
This hypothesis was not supported. 
H1A: There is a significant relationship between older adults’ perceived 
susceptibility to the seasonal influenza and frequency and recency of vaccine. 
This hypothesis was supported based on the following results. 
There were four specific items combined in the perceived seriousness construct. 
Ordinal logistic regression statistics were run between this construct, cue to act, and self-
efficacy and the two dependent variables recency of influenza vaccine. The model fit for 
the null hypothesis can be rejected as the observed significance for the severity construct 
and self-efficacy construct resulted in a p = .002 and the severity construct and cues to 
action resulted in a p =.000. 
The parallel lines for seriousness were tested using the predictor variables 
susceptibility, cues to action and self-efficacy. The null hypothesis of parallelism for risk 
and cues to action, (p = 1.000, -2 log likelihood 168.984) do not have sufficient evidence 
to reject the null hypothesis indicating that ordinal regression using the log-log function 
is appropriate for these data. The null hypothesis of parallelism for risk and self-efficacy, 
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(p = .480, -2 log likelihood 160.588) do not have sufficient evidence to reject showing 
that ordinal regression using the log-log function is appropriate for these data. 
2. Is there a significant relationship between older adults perceived severity to seasonal 
influenza based on CDC influenza guidelines? 
H20: There is no significant relationship between older adults perceived severity 
to seasonal influenza based on CDC influenza guidelines. This hypothesis was not 
supported based on the following results 
H2A: There is a significant relationship between older adults perceived severity to 
seasonal influenza based on CDC influenza guidelines. This hypothesis was 
supported based on the following results 
Examination of the data suggests that there are significant associations between 
the severity construct questions and the dependent variables. There were five specific 
items combined in the severity construct. Ordinal regression statistics were run between 
this construct, predictor variables, cues to action and self-efficacy and the two dependent 
variables. The model fit null hypothesis can be rejected as the severity construct and self-
efficacy construct is a determining factor which resulted in a high degree of significance 
(p = .000) and the susceptibility construct and cues to action were significant as well (p = 
.000). 
The parallel lines for severity question in this section were tested using the 
predictor variables severity, cues to action and self-efficacy. The null hypothesis of 
parallelism for seriousness and cues to action, (p = 1.000, -2 log likelihood 158.896) do 
not have sufficient evidence to reject showing that ordinal regression using the log-log 
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function is appropriate for these data. The null hypothesis of parallelism for severity and 
self-efficacy, (p = .450, -2 log likelihood 128.782) do not have sufficient evidence. 
My intention for research question three was to determine if there was a significant 
relationship between older adult participants’ perception of benefits and the positive 
consequences of annual seasonal influenza vaccine uptake. 
3. Is there a significant relationship between older adults’ perceived benefits and the 
positive consequences of the annual seasonal influenza vaccine uptake? 
H30: There is no significant relationship between older adults’ perceived benefits 
and the positive consequences of the annual seasonal influenza vaccine uptake. 
This hypothesis was not supported and was rejected. 
H3A: There is a significant relationship between older adults’ perceived benefits 
and the positive consequences of obtaining the annual seasonal influenza vaccine. 
This hypothesis was supported based on the following results. 
 Examination of the data suggests that there is a significant relationship between 
the perceived benefits construct and the dependent variable recency of influenza vaccine 
uptake. The items combined in the perceived benefits construct and ordinal regression 
statistics were run between perceived cue to act and self-efficacy construct and the 
dependent variable recency of influenza vaccine. The model fit null hypothesis can be 
rejected as the observed significance for the barriers construct and self-efficacy construct 
resulted in a p = .000 and the barriers construct and cue to act resulted in a p = .000. 
The parallel lines for benefit question in this section were tested using the 
predictor variables, barriers, cues to action and self-efficacy. The null hypothesis of 
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parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood 250.360) do not 
have sufficient evidence to reject showing that ordinal regression using the log-log 
function is appropriate for these data. The null hypothesis of parallelism for barriers and 
self-efficacy, (p = 1.000, -2 log likelihood 272.515) do not have sufficient evidence to 
reject showing that ordinal regression using the log-log function is appropriate for these 
data. 
My intention for research question four was to determine if there was a significant 
relationship between older adult participants’ perceived barriers and discouragement 
concerning the uptake of the seasonal influenza vaccine. 
4. Is there a significant relationship between older adults’ perceived barriers and 
discouragement concerning the uptake of the seasonal influenza vaccine?  
H40: There no significant relationship between older adults perceived barriers and 
discouragement concerning the uptake of the seasonal influenza vaccine. This 
hypothesis was not supported and was rejected. 
H4A: There is a significant relationship between older adults’ perceived barriers 
and discouragement concerning the uptake seasonal influenza vaccine. This 
hypothesis is supported as the dependent variables and the benefit construct relate 
to each other. 
Findings indicate that there is a significant relationship between the perceived 
barriers and the dependent variable recency of influenza vaccine questions. Ordinal 
regression statistics were run between this construct and the dependent variable recency 
of influenza vaccine uptake. The model fit null hypothesis can be rejected as the observed 
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significance for the perceived benefits construct and self-efficacy construct resulted in a p 
= .002 and the benefit construct and cues to action resulted in a p =.000. 
The parallel lines for barrier question in this section were tested using the 
predictor variables severity, cues to action and self-efficacy. The null hypothesis of 
parallelism for benefit and cues to action, (p = .000, -2 log likelihood 382.944) does have 
sufficient evidence to reject showing that ordinal regression using the log-log function 
may not be appropriate for these data. However, the null hypothesis of parallelism for 
benefit and self-efficacy, (p = .972, -2 log likelihood 130.160) do not have sufficient 
evidence to reject showing that ordinal regression using the log-log function is 
appropriate for these data. 
My intention for research question five was to determine if there was a significant 
relationship between older adult participants’ perception perceived cues to action and 
health care providers providing persuasive communications about seasonal influenza 
vaccine. 
5. Is there a significant relationship between older adults’ perceived cues to action and 
health care providers’ persuasive communications about seasonal influenza vaccine?  
H50: There is no significant relationship between older adults’ perceived cues to 
action and health care providers’ persuasive communications about seasonal 
influenza vaccine. This hypothesis was not supported and was rejected  
H5A: There is a significant relationship between older adults’ perceived cues to 
action and health care providers’ persuasive communications about seasonal 
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influenza vaccine. This hypothesis was supported based on the following 
results. 
Examination of the data suggests that there is a significant relation between the 
cues to action construct questions and the dependent variable questions. Ordinal 
regression statistics were run between this construct, cues to action and self-efficacy and 
the dependent variable recency to influenza vaccine constructs. The model fit null 
hypothesis can be rejected as the observed significance for the barriers construct and self-
efficacy construct resulted in a p = .000 and the barriers construct and cue to act resulted 
in a p = .000. 
The parallel lines for cues to action question in this section were tested using the 
predictor variables barriers, and self-efficacy. The null hypothesis of parallelism for 
barriers and cues to action, (p = 1.000, -2 log likelihood 250.243) do not have sufficient 
evidence to reject showing that ordinal regression using the log-log function is 
appropriate for these data. The null hypothesis of parallelism for barriers and self-
efficacy, (p = 1.000, -2 log likelihood 267.924) do not have sufficient evidence to reject 
showing that ordinal regression using the log-log function is appropriate for these data. 
My intention for research question six was to determine if there was a significant 
relationship between older adult participants’ perception of perceived self-efficacy and 
the ability to successfully obtain the seasonal influenza vaccine. 
6. Is there a significant relationship between older adults’ perceived self-efficacy and the 
ability to successfully obtaining the seasonal influenza vaccine?  
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H60: There is no significant relationship between older adults’ perceived self-
efficacy and the ability to successfully obtaining the seasonal influenza vaccine. 
This hypothesis is not supported and was rejected. 
H6A: There is a significant relationship between older adults’ perceived self-
efficacy and the ability to successfully obtaining the seasonal influenza vaccine. 
This hypothesis was supported based on the following results. 
Examination of the data suggests that there are significant associations between 
the self-efficacy construct questions, and the dependent variable questions. Ordinal 
regression statistics were run between the six constructs of the HBM and the dependent 
variable recency of influenza vaccine uptake. The model fit null hypothesis can be 
rejected as the observed significance for the barriers construct and self-efficacy construct 
resulted in a p = .000 and the barriers construct and cues to action resulted in a p = .000.  
The parallel lines for self-efficacy question in this section were tested using the 
predictor variables barriers and cues to action. The null hypothesis of parallelism for 
barriers and cues to action, (p = 1.000, -2 log likelihood 244.225) do not have sufficient 
evidence to reject showing that ordinal regression using the log-log function is 
appropriate for these data. The null hypothesis of parallelism for barriers and self-
efficacy, (p = 1.000, -2 log likelihood 269.920) do not have sufficient evidence to reject 
showing that ordinal regression using the log-log function is appropriate for these data. 
My intention for research question seven was to determine whether there was a 
significant relationship between older adult participants’ perception between the full 
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HBM constructs plus mediating demographic factors such as age, gender, ethnicity, 
occupation and older adults’ perceptions of the seasonal influenza vaccine. 
7. Is there a significant relationship between full HBM constructs plus mediating 
demographic factors such as age, gender, ethnicity, occupation, and older adults’ 
perceptions of the seasonal influenza vaccine?  
H70: There is no significant relationship between full HBM constructs plus 
mediating demographic factors such as age, gender, ethnicity, occupation, and 
older adults’ perceptions of the seasonal influenza vaccine. This hypothesis was 
not supported and was rejected.  
H7A: There is a significant relationship between full HBM constructs plus 
mediating demographic factors such as such as age, gender, ethnicity, occupation, 
and the elderly perceptions of acceptance of the seasonal influenza vaccine. This 
hypothesis was supported based on the following results. 
Examination of the data suggests that there are significant associations between 
the mediating factor age and dependent variable frequency of influenza disease questions. 
Ordinal regression statistics were run between this construct and the dependent variable 
and age. The model fit for the null hypothesis can be rejected as the observed significance 
for age construct resulted in a p = .000. 
The parallel lines for mediating factor age question in this section were tested 
using the predictor variables barriers, cues to action and self-efficacy. The null hypothesis 
of parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood 248.125) do 
not have sufficient evidence to reject showing that ordinal regression using the log-log 
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function is appropriate for these data. The null hypothesis of parallelism for barriers and 
self-efficacy, (p = 1.000, -2 log likelihood 272.936) do not have sufficient evidence to 
reject showing that ordinal regression using the log-log function is appropriate for these 
data. 
My intention for research question eight was to determine whether there was a 
significant relationship between older adult participants’ perception influenza disease and 
recency and influenza vaccine uptake. 
8. Is there significant relationship between influenza vaccine recency and influenza 
disease among older adults? 
H80:  There is no significant relationship between influenza vaccine recency and 
influenza disease among older adults. This hypothesis was not supported 
based on the following results. 
H8A: There is a significant relationship between influenza vaccine recency and 
influenza disease among older adults. This hypothesis was supported based 
on the following results. 
Examination of the data suggests that there are significant associations between 
the six HBM constructs and dependent variable recency of influenza vaccine uptake. 
Ordinal regression statistics were run between the HBM constructs and the dependent 
recency of influenza vaccine uptake. The model fit null hypothesis can be rejected as the 
observed significance for health belief constructs resulted in a p = .000. 
The parallel lines for recency of influenza vaccine question in this section were 
tested using the predictor variables barriers, cues to action and self-efficacy. The null 
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hypothesis of parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood 
242.340) do not have sufficient evidence to reject showing that ordinal regression using 
the log-log function is appropriate for these data. The null hypothesis of parallelism for 
self-efficacy (p = 1.000, -2 log likelihood 272.926) do not have sufficient evidence to 
reject showing that ordinal regression using the log-log function is appropriate for these 
data. 
My intention for research question nine was to determine whether there was a 
significant relationship between influenza disease frequency and influenza vaccine 
uptake and older adults.  
9. Is there a significant relationship between influenza disease frequency and influenza 
vaccine uptake among older adults? 
H90: There is no significant relationship between influenza disease 
frequency and influenza vaccine uptake among older adults. This hypothesis 
is not supported and was rejected.  
H9A: There is a significant relationship between influenza disease frequency 
and influenza vaccine uptake among older adults. This hypothesis is 
supported based on the following results. 
Examination of the data suggests that there are significant associations between 
the mediating factor age and dependent variable frequency of influenza disease. Ordinal 
regression statistics were run between this construct and the dependent variable and age. 
The model fit for the null hypothesis can be rejected as the observed significance for age 
construct resulted in a p = .000. 
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The parallel lines for frequency of influenza disease question in this section were 
tested using the predictor variables barriers, cues to action and self-efficacy. The null 
hypothesis of parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood 
248.326) do not have sufficient evidence to reject showing that ordinal regression using 
the log-log function is appropriate for these data. The null hypothesis of parallelism for 
barriers and self-efficacy, (p = 1.000, -2 log likelihood 272.926) do not have sufficient 
evidence to reject showing that ordinal regression using the log-log function is 
appropriate for these data. 
Summary and Transition 
In this section I have summarized the answers to research questions, provided 
transitional material from the findings and introduced the materials used in Chapter 5. 
The results of this study indicate that older adults’ subjective agreement of their influenza 
vaccine uptake statements are related to their perceptions of benefits from the influenza 
vaccine. The test-retest results showed reliability of the instrument was consistent and 
stable across time and testing. The nine research questions were investigated using factor 
analysis, computed means, reliability and ordinal regression. Factor analysis was 
appropriate for these data, which indicated that the factors were related to the dependent 
variables. Cronbach’s alphas were significant in the reliability testing for all constructs. 
Construct items were grouped into subscales by computing means, based on factor 
analysis, prior to ordinal regression analysis. Hypothesis testing was done based on the 
review of the literature, which indicated that to minimize barriers to influenza vaccine 
uptake, the clinicians’ role is to remind patients about the influenza vaccine safety and 
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effectiveness in preventing influenza disease and its complications. Despite variations in 
the test of parallel lines the null hypotheses were rejected. The nine alternative 
hypotheses were retained. Chapter 5 further explains the summary of the interpretation of 
these findings, generalizations, limitations, social implications of the study, and 
recommendations for future studies.  
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this study was to identify perceived factors that may be associated 
with poor influenza vaccination uptake among older adults. I also explored recency of 
influenza vaccine uptake and frequency of influenza disease within the past year. In this 
chapter, I discuss the interpretation of key findings, generalizations, limitations, 
recommendations for future studies, and implications for practice and social change. 
The study was carried out in three senior centers in Brooklyn, New York. The 
overall number of elderly participants who responded to the survey invitation was 147. 
The results indicated that 92% of older adults received the seasonal influenza during the 
2014/2015 flu season. This high vaccination uptake could be the success of influenza 
vaccination campaigns and the extensive media education regarding the influenza related 
deaths in the United States and around the world. I found that perceptions of cues to 
action, such as healthcare provider reminders, were more likely to influence those older 
adult participants who had prior vaccination. Partners from the CDC’s 2011-12 Influenza 
Vaccination Communication Campaign reported that 80 % of participants were likely to 
take the influenza vaccine due to media education while 19% were less likely to take the 
influenza vaccine (as cited in Sheedy, 2011). There is evidence on the effectiveness of 
interventions that apply new social media such as text messaging, smartphones 
application, YouTube videos, and Facebook (Odone, 2015). Targeted websites and 
portals for physicians and healthcare providers promoted vaccination uptake and 
increased vaccination coverage (Odone, 2015). According to Odone (2015), the 
103 
 
 
effectiveness of vaccine uptake using these new media sources are as follows: text 
messaging (37%), smartphone applications (5%), YouTube videos (5%), and Facebook 
(5%), targeted websites and portals (21%), software for physicians and health 
professionals (21%), and email communication (5%). In addition, the current reminder 
from health care providers (90%) has a significant effect on older adult participants 
perceived behaviors concerning vaccine uptake (Odone. 2015).   
Interpretation of the Findings 
In this section, I present whether the study findings confirm, disconfirm, or extend 
knowledge in the discipline in comparison to current literature. A main goal of the study 
was the development of a new instrument. Evidence from factor analysis is discussed in 
terms of reliability and constructs validity of the questionnaire. In addition, the analysis 
and interpretation of the findings are presented based on the conceptual framework.   
Factor analysis and correlations were performed to analyze the reliability 
(test/retest) of the newly developed scale and findings indicated that the new scale had a 
reliability coefficient (r2 = 0.9) calculated from the data for the first group that indicated 
high test-retest reliability. Factor analysis verified the constructs of the new scale by 
calculating Cronbach’s alphas.   
Previous literature indicated racial and ethnic differences in beliefs where whites 
were more likely to believe the influenza vaccine was very effective in preventing 
influenza compared to African Americans (Blacks) and Hispanics (Wooten, Wortley, 
Singleton, & Euler, 2012). In the present study, the odds of influenza vaccine uptake 
indicated that there were no significant differences between European Americans 
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(Whites), African Americans, or Hispanics concerning influenza vaccine uptake (OR = 
1.20, 95% CI [0.64, 2.30], p =.58). Zimmerman, Raymund, Janosky, Norwalk, and Fine 
(2003) compared self-report with medical record abstraction of older adults in several 
locations. Their findings indicated that Veterans Association patients had the highest 
sensitivity and lowest specificity for both influenza and pneumococcal vaccines. While 
over 90% of the responders stated they had vaccine uptake, verification from medical 
records indicated that only 51% had received the vaccine. The opposite was true for 
inner-city health centers. The findings from the homogeneous senior center participants 
are likely to reflect these two types of health centers; however, the associations between 
self-reported perceptions and vaccination uptake in the present study remain stable.  
Older adult participants believed that the influenza vaccine is very effective; self-
reported vaccination was substantially higher across all racial/ethnic groups. To identify 
older adults perceived behaviors that contributed to poor uptake of the seasonal influenza 
vaccine among older adults, I developed nine research questions, a 33-item tool using the 
HBM to explore the perception of the older adults concerning the seasonal influenza 
vaccine uptake, demographic mediating factors, frequency of the influenza disease, and 
recency of influenza vaccine uptake. In this study, the ordinal regression revealed that 
there were significant correlations between older adults’ perceptions of the influenza 
disease and influenza vaccine uptake (p = 0.05).   
Research Question 1: Perceived Susceptibility  
Ordinal regression analysis was performed to answer this research question. 
Perception of influenza infection risk was significant as a predictor for older adult 
105 
 
 
participants. Older adults who believed that they were at greater risk for contracting 
influenza were more likely to obtain influenza vaccination. This finding addresses the 
construct of perceived susceptibility, where it refers to an individual’s beliefs about the 
chances of getting a condition (Glanz et al., 1997; NCI, 2005). The computed sample 
mean for the specific perceived susceptibility was 5.24. Most participants agreed or 
strongly agreed with the items related to the risk of contracting seasonal influenza. The 
results of the ordinal regression showed that there were significant correlations between 
the perceived susceptibility and predictor variables cues to action and self-efficacy and 
dependent variables recency of influenza vaccine and frequency of influenza disease. 
Yamamoto et al. (2002) reported that perceived threat and net benefit were associated 
with intention, and net benefit had a stronger correlation with intention than did perceived 
benefit and barriers. In this study, I found that older adults agreed or strongly agreed 
with the susceptibility of influenza infection items. 
Research Question 2: Perceived Severity  
Perceived severity is an individual’s belief about the seriousness of influenza and 
its prevention (Glanz, K., Rimer, B.K. & Lewis, 2002). Ordinal regression analysis was 
run on each independent variable: susceptibility, severity, benefits, barriers, cues to 
action, self-efficacy, and the demographic modifying factors as well as the dependent 
variables: perceived recency of influenza vaccine uptake and frequency of influenza 
disease. Perception of the seriousness of influenza disease was found to be significant as 
a predictor of older adults’ uptake of the influenza vaccine. This finding indicated that 
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perceptions of the seriousness of influenza disease and its complications correlated with 
most of the other predictor variables as well as the two dependent variables. 
My findings confirm that the extent of knowledge and awareness of influenza 
disease and vaccine availability contributed to the importance of influenza vaccine uptake 
among the elderly when comparing them with reports found in the peer-reviewed 
literature. The computed sample mean for the specific seriousness construct was 5.5. 
Most participants agreed or strongly agreed with the items related to the seriousness of 
influenza disease. Items that addressed the perceived seriousness of contracting seasonal 
influenza disease showed that a higher percentage of vaccinated older adults believed that 
influenza was a serious concern. Ordinal regression was performed, and it was identified 
that there were significant correlations. This finding is not consistent with the current 
literature. Maurer et al. (2010) reported that perceived seriousness of seasonal influenza 
and swine flu risks in adults revealed that swine flu was believed to be more serious and 
therefore the uptake of vaccination was lower due to perception by the public who 
believes it was less safe. However, the current study suggests that older adults were more 
likely to consider seasonal influenza as a serious illness that would negatively affect their 
everyday functioning and quality of life.  
Research Question 3: Perceived Barriers 
Perceived barriers to influenza immunization is the belief about the influenza 
vaccine and psychological costs of taking the vaccine (Glanz, Rimer, & Lewis, 2002). 
Ordinal regression analysis was used to answer the perceived barrier construct. The 
perception of the barriers of the influenza vaccine was found to be a significant predictor 
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in addressing influenza vaccine uptake among older adults. This finding indicated that the 
perceptions of the barriers of influenza vaccine was with most related to predictor 
variables benefits, cues to action, self-efficacy, as well as the two dependent variables 
recency of influenza vaccine and frequency of influenza disease. When comparing results 
with what has been found in the peer-reviewed literature, it was identified that my 
findings confirm some of the existing literature. The computed sample mean for the 
specific barriers construct was 4.60, where most participants disagreed or strongly 
disagreed with the items related to the barriers of influenza vaccine. However, the ordinal 
regression was found to have significant correlations. This is consistent with the current 
literature in relation to the barriers. Johnson et al. (2008) reported that among the most 
common barriers to immunizations were lack of physician recommendations and 
mistaken assumptions while other reasons cited by healthcare providers were side effects, 
fear of needles, and lack of insurance coverage as reasons and practice issues, such as a 
lack of an effective reminder system. 
Research Question 4: Perceived Benefit  
Perceived benefit is the belief about the effectiveness of taking the influenza 
vaccine to reduce risk of getting influenza and the related complication (Glanz, Rimer, & 
Lewis, 2002). Ordinal regression analysis was done to answer research question, 
perceived benefit. Perception of the benefit of addressing the influenza vaccine was 
found to be significant as a predictor of elderly participants’ uptake of the influenza 
vaccine. This finding is not surprising given that perceptions of the benefit of influenza 
vaccine correlated with predictor variables, barriers, cues to action, and self-efficacy, as 
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well as the two dependent variables of recency of influenza vaccine uptake and frequency 
of influenza disease. 
My findings extend knowledge in the discipline when comparing them with what 
has been found in the peer-reviewed literature. The computed sample mean for the 
specific benefit construct was 5.42, where most participants agreed or strongly agreed 
with the items related to the benefit of influenza. Ordinal regression showed that there 
were significant correlations. This is consistent with the literature that reported on 
perceived benefits of the influenza vaccination due to the prevention of the seasonal 
influenza disease, decreased severity of symptoms, less time off, a lower chance of 
passing influenza to family and friends, and prevention of complication and hospital 
admission. Chen et al. (2007) supported the contention that groups with major long-term 
conditions, women, older people, and those who have needed or are likely to require 
hospital admission are more likely to decide to receive an annual influenza vaccination. 
Research Question 5: Perceived Cues to Action 
Cues to action are strategies to activate readiness (Janz & Becker, 1984) that can 
be described as events, either bodily symptoms such as physical symptoms of a health 
condition or environmental such as media publicity that motivate people to take an 
action. Ordinal regression analysis was done to answer perceived cues to action construct. 
Perception of the cues to action of the influenza vaccine was found to be significant as a 
predictor in addressing influenza vaccine uptake among the elderly. This finding 
indicated that perceptions of the cues to action of influenza vaccine was most related to 
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predictor variables barriers, benefits, and self-efficacy as well as the two dependent 
variables recency of influenza vaccine and frequency of influenza disease. 
When comparing results with what has been found in the peer-reviewed literature, 
it was identified that my findings confirm some of the existing literature. Physician and 
other clinicians’ recommendations and reminder systems for the influenza vaccine are 
known to increase vaccination rates significantly (Anderson et al., 2008). The computed 
sample mean for the specific cues to action construct was 5.60, where most participants 
agreed or strongly agreed with the items related to the cues to action of influenza vaccine 
uptake. The ordinal regression was found to have significant correlations. 
Research Question 6: Perceived Self-Efficacy  
Perceived self-efficacy is the confidence and the ability to successfully make 
informed decisions (Glanz et al., 2002). Ordinal regression analysis was carried out to 
answer perceived self-efficacy construct. Perception of the perceived self-efficacy of the 
influenza vaccine was found to be significant as a predictor in addressing influenza 
vaccine uptake among older adults. This finding indicated that perceptions of the 
perceived self-efficacy concerning the influenza vaccine uptake was most related to 
predictor variables barriers, benefits, and cues to action as well as the two dependent 
variables recency of influenza vaccine and frequency of influenza disease. 
Findings confirm those of Zimmerman et al. (2003) who concluded that patient 
education and recommendation for the influenza vaccination by healthcare providers 
increases likelihood of patient vaccination uptake by eliminating misconceptions, 
vaccine-related concerns, and myths. The computed sample mean for the specific self-
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efficacy construct was 5.64, where most participants agreed or strongly agreed with the 
items related to the self-efficacy of influenza vaccine uptake. The ordinal regression was 
found to have significant correlations. 
Research Question 7: Demographic Mediating Factors 
Demographics mediating factors in this study found that the vaccinated were not 
statistically different with regards to most of the demographic variables: gender, age, 
ethnicity, education, annual income, and type of residence. Evidence for the clinical 
efficacy of the influenza vaccine among the older adults, especially those with chronic 
disease, can reduce mortality and hospital admissions (CDC, 2013). Mediating factor age 
was tested using the six HBM predictor variables: susceptibility, severity, barriers, 
benefit, cues to action, and self-efficacy. Ordinal regression statistics were run between 
the six HBM subscales, which indicated that there were no statistical significant 
differences across age groups of older adults, resulting at a 5% significance level. 
However, there are significant associations between the mediating factor age and 
dependent variable of frequency of influenza disease. When comparing results with what 
has been found in the peer-reviewed literature, it was identified that my findings confirm 
some of the existing literature concerning the importance of influenza vaccine among the 
elderly. Johnson et al. (2008) reported that by counseling older adult patients and by 
acknowledging their fear and susceptibility to influenza, it can help them to make 
changes in their behavior that will motivate them to make informed decisions. 
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Research Question 8: Frequency of Influenza Disease 
Frequency of influenza disease refers to measurement of the most recent episode 
of influenza disease 1 = ≤1 year (CDC, 2013). Logistic regression analysis was used to 
answer research question about frequency of influenza infection. Research questions 
predicting frequency of influenza infection were tested using the six HBM constructs: 
severity, susceptibility, barriers, benefits, cues to action, and self-efficacy. Ordinal 
regression was run using predictor variables barriers, benefits, cues to action, and self-
efficacy. There was not sufficient evidence to reject the null hypothesis. Ordinal 
regression statistics were run between frequency of influenza disease and age, and the 
null hypothesis was rejected because it indicated that age makes no difference. When 
comparing results with what has been found in the peer-reviewed literature, it was 
identified that my findings confirm some of the existing literature. Studies have shown 
that older adults who had received the influenza vaccine in a year or less had a decreased 
incidence in influenza and its complication (CDC, 2010). 
Research Question 9: Recency of Influenza Vaccine Uptake 
Recency of influenza vaccine uptake refers to measurement of the most recent 
influenza vaccine uptake. Ideal = (1 = ≤ 1 year) (CDC, 2013). Logistic regression 
analysis was used to answer research question recency of influenza vaccine uptake. The 
recency of influenza vaccine question were tested using the six construct of the HBM, 
severity, susceptibility, barriers, cues to action and self-efficacy. Ordinal regression was 
run using predictor variables barriers, cues to action and self-efficacy. There was not 
sufficient evidence to reject the null hypothesis. When comparing results with what has 
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been found in the peer-reviewed literature it was identified that my findings confirms 
some of the existing literature. Studies have shown that recency of influenza vaccine 
uptake within one year or less has proven to be safe and effective in preventing influenza 
infection and its complication among the elderly (CDC, 2010). Studies have reported that 
there is an age-related decline in immune responses in older adults causing a greater 
susceptibility to infection and reduced responses to vaccination (Skowronski, Tweed, 
Serres, 2008). Other studies have indicated that a low protective effect of the influenza 
vaccine suggest a decline in vaccine effectiveness in older adults over time post 
vaccination therefore annual influenza immunization of high-risk populations against 
influenza remains the most important preventive method (Castilla, Martinez-Baz, 
Martinez-Artola, et al., 2013). 
Limitations 
In every study, there is a possibility of limitations. Since this study uses a cross-
sectional design, there can be limitations with the strength of the internal validity. The 
study was also limited to self-report of seasonal influenza vaccination status, truthfulness 
of participant’s responses, either because they cannot remember or because they wish to 
present themselves in a socially desirable manner. In addition, external validity is a 
limitation as data on disease diagnosis and vaccination uptake was limited to self-
administration without verification of medical records. Due to the nonrandom selection of 
participants, the study was limited by self-selection of volunteer male and female adults 
age 65 and older who attended the selected senior centers Brooklyn, New York.  
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The possible biases that could influence study outcomes are those due to non-
response. To minimize this type of bias the sample size was large enough to estimate the 
prevalence of the influenza vaccine uptake among the elderly in the selected demographic 
areas of Brooklyn. A potential limitation is that the study did not use random sampling 
and the results may not be generalizable to all older adult population hesitant to receive 
the seasonal influenza vaccination. However, the development of a new instrument 
required quick and high participation from a homogeneous population.  
Recommendations 
The recommendations for further research that are grounded in the strengths and 
limitations of the current study, as well as the current literature are discussed in this 
section. The following are the recommendations for further studies: 
● Additional studies should be done on more specific correlations related to older 
adults’ perceptions in both controlled and uncontrolled community settings.  
● Research using a random selection of elderly in the community involving recency 
of influenza immunization uptake and frequency of influenza disease within one 
year or less.  
● Future studies should further examine the effectiveness of structured influenza 
vaccine interventions such as physicians and other clinician reminders, television 
advertising, targeting social media networks, and community organizations.  
● Get family members more involved by asking them to get vaccinated or to 
accompany older adult family members to vaccine sites.   
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These recommendations can help provide future researchers, public health 
professionals and healthcare clinicians to work together to increase influenza vaccination 
rates in the general population. 
Implications for Social Change 
Positive social change that can be derived from this study is identifying the gap in 
knowledge related to direct care clinicians concerning the importance of influenza 
vaccine and the contributory aspects in reducing the influenza complication among older 
adults. Although the constructs perceived susceptibility, seriousness and barriers may 
contribute to difficulties accepting influenza vaccination; clinicians can make a difference 
by teaching their patients about safety and effectiveness of the seasonal influenza 
vaccine. In this study the constructs benefit, cues to action and self-efficacy were 
determinants that made a positive difference in the perceived older adults’ beliefs about 
seasonal influenza vaccination uptake. This research captured the perceptions of the older 
adults concerning their perceived belief about influenza disease and gave a better 
understanding that the influenza vaccine uptake among older adults can be improved 
through education and information received from the clinicians. This information can 
also help clinicians and public health officials to be more involved in educational 
seminars and follow CDC (CDC, 2014) and evidence based guidelines to improve the 
seasonal influenza vaccine uptake among older adults. The HBM can also be a useful tool 
in understanding beliefs and perceptions of older adults concerning influenza vaccination 
and guide the choice of the clinical interventions for elderly patients who either directly 
or indirectly oppose the influenza vaccination (Glanz, Marcus Lewis, & Rimer, 1997). 
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Practice Recommendations 
Recommendations for practice include increasing knowledge and awareness of 
clinicians by addressing methods of informing their patients during health visits; 
clinicians must also overcome their own barriers that prohibit influenza vaccine uptake; 
and also, making clinicians more aware of their roles in influenza prevention. Most 
importantly, review of health policies based on the risk factors of influenza disease, 
severity, evidence of the influenza vaccine safety, efficacy, and the effectiveness in 
preventing influenza complication among the older adults can improve vaccine uptake. 
The results of this study lead us to believe that clinicians understanding of current health 
policies and patients’ perceptions of influenza vaccine can lead to improvement in 
clinical practice and standards of care. 
Conclusion 
This research captured the perceptions of the older adults concerning their 
perceived belief about influenza disease and gave a better understanding that the 
influenza vaccine uptake among older adults can be improved through education and 
information received from the clinicians. The significance of the findings suggest older 
adults’ perception of seasonal influenza disease and vaccine uptake as a method of 
prevention and its association with clinical practice in raising awareness about the safety 
and effectiveness of the influenza vaccine. In this study, I examined the perceptions of 
older adults concerning the influenza vaccine uptake which was below the national 
average. To increase vaccination uptake among older adults, this research suggests there 
is a need to address health beliefs, influenza vaccine side effects, safety and effectiveness. 
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The results of this study support the need for continued patient and clinician education, 
and awareness of effective guidelines that support influenza vaccine uptake among older 
adults. The data indicate that older adults’ perception of the seriousness, susceptibility 
and barriers, are triggered by predictors including perceived benefits, cues to action and 
self-efficacy. These findings support clinical strategies that promote the influenza 
vaccination uptake. Implementing more clinicians’ reminders and media campaigns 
especially during the influenza season can be an asset in improving influenza vaccine 
uptake. 
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Appendix A: Expert Panel Recruitment Letter 
 
I am working on my dissertation related to Correlates of Influenza Vaccine 
Uptake Among the Elderly and need an expert panel to review my newly created survey. I 
am looking for professionals that have either academic background in content or 
methodology expertise, have research experience in healthcare, or practice as a medical 
doctor or nurse practitioner. I am reaching out to you as I feel you meet one of these 
criteria and I feel you would be a vital asset to my expert panel. 
As a member of an expert panel you receive all the information the typical study 
participant will receive and provide comments on the items in the survey. I will ask you 
to look strictly at the content of the survey and wording of the questions/statements and 
not the format of the survey. The official survey format will be done on a Word 
document which you will review. You would add comments where you feel changes are 
needed on the form available titled “Form for Review and Evaluation of Validity and 
Reliability by a Panel of Experts for Quantitative Instrumentation of “Older Adults 
Perceptions of Influenza Disease and Influenza Vaccine Uptake”. I may ask you to 
review revisions made based on the comments received, however I will try to get these 
back to you within 7 to 10 days. The survey and form are attached above for you to 
review.  
Thank you for your time and consideration. 
I have also attached my Curriculum Vitae for information on my background. 
Sincerely, 
Cheryl Hilliman, RN, MSN, FNP, WCCN 
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Appendix B: Panel of Experts Review Form 
 
Form for Review and Evaluation of Validity and Reliability by a Panel of Experts for 
Quantitative Instrumentation of Elderly Perceptions of Influenza Disease and Influenza 
Vaccine Uptake 
Instructions: Please review the attached Quantitative Instrumentation of Elderly 
Perceptions of Influenza Disease and Influenza Vaccine Uptake and respond to the 
following questions regarding the construction, validity and potential reliability for the 
Quantitative Elderly Perceptions of Influenza Disease and Influenza Vaccine Uptake 
concerning the phenomenon being researched, examined, assessed, evaluated or 
measured. 
Section I. VALIDITY EVALUATION 
A test, survey, questionnaire, evaluation or assessment instrument is valid to the extent 
that the instrument measures the construct(s) that the instrument purports to measure.  
1. Instrument Construction:   
1. (a). Are the instructions for completing the instrument clear? 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
1.(b). Is the application and results of the Quantitative Instrumentation of Elderly 
Perceptions of Influenza Disease and Influenza Vaccine Uptake adequately reflected in 
this instrument? 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
1. (c). What items would you add? 
1. (d). What items would you delete? 
2. Content Validity:   
Will the scores yielded by Quantitative Instrumentation of Older Adults Perceptions of 
Influenza Disease and Influenza Vaccine Uptake adequately represent the content or 
conceptual domain of the construct being measured? In other words, does the instrument 
have adequate and appropriate items that constitute a representative sample of the 
complete domain of items used to generalize the construct being measured? Please see 
the attached table of specifications [instrument blueprint] that reflect which items and 
how many items within the instrument are designed to measure each type of content 
domain.  
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
3. Construct Validity:   
Quantitative Instrumentation Older Adults Perceptions of Influenza Disease and 
Influenza Vaccine Uptake is designed to measure Older Adults Perceptions of Influenza 
Disease and Influenza Vaccine Uptake, Recency of influenza vaccine uptake= (1=≤1 
year) and Frequency of Influenza disease = (1=≤1 year). Please see constructs definition: 
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Insert of constructs definition based on Glanz, K., Marcus Lewis, F. & Rimer, B.K. 1997; 
Rosenstock, Strecher, Becker, 1988. The health belief model has six constructs and the 
mediating demographic factors which support the six constructs, and its underlying 
concept is that health behavior is determined by a person’s beliefs or perceptions about 
influenza disease and vaccine uptake and techniques to decrease influenza disease 
among older adults. The main constructs are perceived susceptibility, severity, benefits, 
barriers, cues to action, self-efficacy and the mediating demographic factors which 
supports the six core perceived concepts. Perceived susceptibility evaluates the 
perception of the risk of developing the influenza disease and lends to the motivation to 
take the influenza vaccine to decrease that risk of getting influenza disease. The construct 
of perceived severity evaluates individual's beliefs about the seriousness of influenza 
disease and how to avoid it. Perceived benefit evaluates the participants’ beliefs about 
the chances of getting influenza disease and the potential positive impact of the uptake of 
the influenza vaccine to decrease the risk of influenza disease. Perceived barriers 
evaluates participants’ opinion of what is stopping them from making the decision to 
adopt a new behavior that can protect and prevent influenza disease. Self-efficacy 
evaluates the participants’ perception of their competence to successfully act in seeking 
the influenza vaccine. Demographic mediating factors are the modifying variables such 
as age, sex, race, ethnicity, and education that may interfere influenza vaccine uptake 
indirectly by affecting perceived susceptibility, benefits, barriers, cues to action and self-
efficacy. Recency of influenza is evaluated by measuring the most recent influenza 
vaccine uptake.  Ideal = (1=≤1 year). 
 
3. (a) Does the Quantitative Instrumentation of Elderly Perceptions of Influenza Disease 
and Influenza Vaccine Uptake represent concepts or constructs it should represent and 
does not represent concepts it should not represent?  In other words, does the Quantitative 
Instrumentation of Older Adults Perceptions of Influenza Disease and Influenza Vaccine 
Uptake adequately represent the constructs it purports to represent? 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
3. (b) Is the Quantitative Instrumentation of Older Adults Perceptions of Influenza 
Disease and Influenza Vaccine Uptake inclusive of the important dimensions or facets of 
the constructs it purports to measure. 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
3. (c) Does the Quantitative Instrumentation of Older Adults Perceptions of Influenza 
Disease and Influenza Vaccine Uptake avoid excess reliable variance, ensuring no items 
are easier or harder for some respondents in a manner relevant to the interpreted 
construct? 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
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D. Face Validity 
Does the Quantitative Instrumentation of Older Adults Perceptions of Influenza Disease 
and Influenza Vaccine Uptake look valid?  Does it appear to represent a measure of the 
construct it purports to measure? 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
E. Item Bias 
Does the wording or placement of an item avoid affecting someone’s response? 
(This includes the avoidance of double-barreled items, words or phrases, which raise 
emotional red flags, ambiguous wording, gender bias, racial/ethnic bias, and the 
manipulative placement of an item or wording of an item) 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
 
F. Consequential Validity 
Does the Quantitative Instrumentation of Elderly Perceptions of Influenza Disease and 
Influenza Vaccine Uptake instrument embody desirable values and have potentially 
positive consequences for the discipline or field it reflects?  
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
Section II. RELIABILITY EVALUATION 
A test, survey, questionnaire, evaluation or assessment instrument is reliable to the extent 
that whatever construct(s) the instrument measures, it measures the construct(s) 
consistently.  
A. Internal Consistency 
Are the items that make up the Quantitative Instrumentation of Older Adults Perceptions 
of Influenza Disease and Influenza Vaccine Uptake internally consistent with each 
component and/or the constructs being examined, assessed, evaluated or measured? 
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
B. Potential for Reliability (Potential for Consistent Responses) 
Understanding that research participants completing this instrument will vary in their 
understanding and experience with the Older Adults Perceptions of Influenza Disease 
and Influenza Vaccine Uptake and thus vary in their responses, is there anything about 
this instrument that would lead you to believe that this instrument would not consistently 
measure Older Adults Perceptions of Influenza Disease and Influenza Vaccine Uptake.  
[   ] Yes 
[   ] No (if no, please explain) 
[   ] Yes provided the following actions are taken:   
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Please provide any additional comments, suggestions for improvement, and/or any other 
thoughts regarding the construction, how the survey to be easier to complete, validity 
and/or reliability of the Quantitative Instrumentation of Older Adults Perceptions of 
Influenza Disease and Influenza Vaccine Uptake 
 
 
Panel Member 
 
Printed or typed Name: 
 
 Title:  
 
 Department:  
 
Organization:  
 
Location:  
 
Signature: ____________________________ Date: ______________________ 
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Appendix C: Community Research Partner Review Form 
 
Community Research Partner Name: 
Contact Information 
Date 
Dear Cheryl Hilliman,  
Based on my review of your research proposal, I give permission for you to conduct the 
study entitled “Correlates of Influenza Vaccination Uptake among the Older Adults” 
within the Christopher C. Blenman Senior Center.  As part of this study, I authorize you 
to recruit all (a) men and women, (b) age 65 years and older, (c) English speaking, (d) 
oriented to person, time and place, (e) members of the selected senior citizen centers and 
(f) able to read and understand the English language to be in the study.  Individuals’ 
participation will be voluntary and at their own discretion.  The purpose of the survey is 
to identify perceived factors that may be associated with poor influenza vaccination 
uptake among the older adults. The information that is collected will be analyzed and 
added to the future knowledge of how to Identify: 
● Strategies for maintaining and sustaining change related to increasing influenza 
vaccine uptake; and   
● Future implications of using the Health Belief Model to assess the perception and 
beliefs of the older adults’ population especially in Brooklyn, New York.  
 
We understand that our organization’s responsibilities include: a secure area which will 
be allocated to you to complete the survey. We reserve the right to withdraw from the 
study at any time if our circumstances change.  
I will be complying with your site’s research policies and requirements, including 
participants’ safety and confidentiality. 
I confirm that I am authorized to approve research in this setting and that this plan 
complies with the organization’s policies. 
I understand that the data collected will remain entirely confidential and may not be 
provided to anyone outside of the student’s supervising faculty/staff without permission 
from the Walden University IRB.   
Sincerely, 
Authorization Official 
Contact Information 
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Appendix D: Survey Rating Form 
 
Survey Rating Form 
 
This survey explores the perception related to influenza vaccine uptake among the 
elderly. Participation in this survey is completely voluntary. Your answers to each 
question is important, so please complete each item on the form to the best of your 
ability. Your responses must be honest. Each item to the concept of health belief model 
on the survey must be read carefully and answered by selecting one of the numbers on the 
5-point scale that represents how relevant you believe it is measuring the concept of the 
perceived action. All the information you provided will help clinicians to develop better 
influenza vaccine programs for the elderly in the future.  
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ITEMS 1. 
Strongly 
Disagree 
2. 
Disagree 
3.  
Neither 
Agree or 
Disagree 
4. 
Agree  
5. 
Strongly 
Agree 
1. If I get the seasonal influenza virus I will get sick. 1 2 3 4 5 
2. If I get the seasonal influenza virus I will lose 
income. 
1 2 3 4 5 
3. If I get the seasonal influenza virus other members 
in my home will get sick. 
1 2 3 4 5 
4. If I get the seasonal influenza virus I will die 1 2 3 4 5 
5. I am at risk for getting the seasonal influenza virus 1 2 3 4 5 
6. My family members are at risk for getting the 
seasonal influenza virus. 
1 2 3 4 5 
7. I feel knowledgeable about my risk of getting the 
seasonal influenza virus. 
1 2 3 4 5 
8. I will have side effects from the seasonal influenza 
vaccine. 
1 2 3 4 5 
9. I will get sick from the seasonal influenza vaccine. 1 2 3 4 5 
10. I will die from the seasonal influenza vaccine. 1 2 3 4 5 
11. The seasonal influenza vaccine will be painful. 1 2 3 4 5 
12. The seasonal influenza vaccine will be expensive. 1 2 3 4 5 
13. It is inconvenient to get the seasonal influenza 
Vaccine 
1 2 3 4 5 
14. There is a shortage of the seasonal influenza 
vaccine 
1 2 3 4 5 
15. If I receive the seasonal influenza vaccine, I will 
not get sick from the seasonal influenza virus 
1 2 3 4 5 
16. If I receive the seasonal influenza vaccine it will 
prevent complications from the seasonal influenza 
disease 
1 2 3 4 5 
17. Seasonal influenza vaccines are safe. 1 2 3 4 5 
18. I will take the seasonal influenza vaccine if my 
doctor or my nurse said it is important 
1 2 3 4 5 
19. I will take the seasonal influenza vaccine if a 
family member or significant other said it is 
important 
1 2 3 4 5 
20. I will take the seasonal influenza vaccine if I see a 
TV ad that said it is important 
1 2 3 4 5 
21. I will take the seasonal influenza vaccine if the 
interdisciplinary team at my clinic reminds me. 
1 2 3 4 5 
22. I am confident that I can obtain the seasonal 
influenza vaccine 
1 2 3 4 5 
23. I am confident that my day to day performance will 
not be adversely impacted by taking the seasonal 
influenza vaccine 
1 2 3 4 5 
24. I am confident that the seasonal influenza vaccine I 
will take will not exposed me to any side effects or 
death 
1 2 3 4 5 
25. I am confident that seasonal influenza vaccine will 
help to prevent me from getting the seasonal 
influenza throughout the influenza season. 
1 2 3 4 5 
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Demographic Factors 
 
Please circle the response that most closely corresponds to you. As with the survey, all 
responses will be kept confidential 
 
What is your gender?  
 
 Male   
 Female  
What is your current age?   
 
 65 -70   
 70- 75  
 75 or greater 
What Race/Ethnicity group do you consider 
yourself?   
 European Americans 
 African Americans  
 Hispanic  
 Asians 
 Other, specify:__________________. 
What is your highest educational 
attainment?  
 Grade School  
 Some High School  
 High School Diploma/GED   
 Some College  
 Bachelor Degree  
 Graduate/Professional Degree 
What is your family’s annual income?  Under $10,000  
 $10,000 - $19,999 
 $20,000 - $29,999 
 $30,000 - $39,999 
 $40,000 - $49,999 
 $50,000 - $59,999 
 $60,000 or above. 
Where do you reside?  Family house 
 Own house alone 
 Residence for senior citizens,    
 Other, specify: ……………………….. 
How many times did you have influenza 
attack in the past one year? 
 0 time   
 1 time 
 2 times 
 3 times  
 4 or more times 
How recently did you receive influenza 
vaccination? 
 Never  
 More than three years,  
 2-3 years ago,  
 Last year 
 This year.  
END. Thank you for completing the Influenza Vaccine Survey!  
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Appendix F: Letter of Invitation for Volunteers for Test-Retest Survey 
 
 
Dear Volunteers, 
 
I am inviting 50 older adults who will volunteer to participate in a study survey which 
will include test/retest sample to help the validity of this study. If you volunteered to 
participate in the test-retest survey the same test will be administered two times.  
The purpose of this study is to identify perceived belief about uptake about influenza 
vaccine uptake. I feel this research is important to identify the belief that is responsible to 
poor influenza vaccine uptake. If you know any other older adults that might be willing to 
participate in the survey test-retest, please invite them so they might complete my survey. 
I hope to finish my data collection by July 30, 2015. Once I have my final dissertation 
approved I hope to disseminate my findings anyone who is interested. Please contact for 
any questions or concerns at XXX@waldenu.edu. 
Thank you, again, for your help! 
Cheryl Hilliman RN MSN FNP WCCN 
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Appendix G: Test/Retest Participant Reminder Emailing 
 
Dear Fellow Participants, 
This is a reminder to participate in the Retest for the research study as previously 
discussed. I selected 50 older adults who volunteered to participate to complete the study 
survey a second time and be included in the test/retest sample to help the validity of this 
study. These participants practice autonomously and are members of the senior centers in 
Brooklyn, New York. I would like to, again, assess older adults’ perceptions of influenza 
disease and influenza vaccine uptake. The purpose of this study is to identify perceived 
beliefs that may contribute to poor uptake of the influenza vaccine among older adults. 
The survey should take less than 15 to 20 minutes to complete. 
Again, any information you provide will be kept confidential because no 
signatures is required. The researcher will not use your personal information for any 
purposes outside of this research project. Also, the researcher will not include your name 
or anything else that could identify you in the study reports. Data will be kept secure by a 
password protected computer that only the researcher will have access. Data will be kept 
for a period of at least 5 years, as required by the university. 
If you are still interested, I will be at the senior center at 9 am Wednesday morning which 
is within 5 days from todays’ date.   
Please contact me at the information for any questions or concerns. If you have 
any questions about participants’ rights, it can be directed to a Walden University 
representative at IRB@waldenu.edu. 
Thank you  
Cheryl Hilliman, RN, MSN, FNP, WCCN 
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Appendix H: Letter of Invitation Prospective Participants 
 
Study Title: Correlates of Influenza Vaccination Uptake among Older Adults 
 
Dear Prospective Participants 
You are cordially invited to participate in a research among older adults. Your senior 
citizen center is invited to participate in this study because you are between the ages of 65 
or older which makes you eligible for the study. The information that is collected will be 
analyzed and added to the future knowledge of how to Identify: 
● Strategies for maintaining and sustaining change related to increasing influenza 
vaccine uptake; and   
● Future implications of using the Health Belief Model to assess the perception and 
beliefs of the older adults’ population especially in Brooklyn, New York.  
It is very important that you read the entire consent form before agreeing to participate in 
the study. This study is being conducted by Cheryl Hilliman, RN, a current doctoral 
candidate at Walden University. 
Background Information: Seasonal influenza outbreak usually occurs in the United 
States in late fall through early spring, causing severe illnesses and death, especially 
among the elderly and children (CDC, 2012). Although influenza affects all ages, the 
elderly is particularly vulnerable because they often have chronic illnesses which put 
them at a greater risk for influenza complications, including pneumonia (Molinari, et al, 
2007). U. S. Census Bureau 2011 reported influenza and pneumonia is the 7th leading 
cause of death among the older adults and the annual rate of influenza-associated death 
among ages 65 and older is 45,321 deaths per 100,000 persons. The results obtained from 
this survey can be used to develop interventions that are specific to methods of 
decreasing the prevalence of influenza and its complication among older adults. If you 
agree to participate in this study please sign and return this letter of invitation to Cheryl 
Hilliman, email cheryl.hilliman@waldenu.edu  
I agree to participate in this study 
Signature (first name and last name initials only): ___________ Date: _______________ 
Senior Citizen Center Location________________ 
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Appendix I: Flyer Advertising Influenza Vaccine Research Study 
 
Research Study to Identify why the Influenza Vaccine Uptake Rates are decreasing 
among the Older Adults in Brooklyn, New York 
 
Seasonal influenza is a contagious airborne respiratory disease that spreads from person 
to person during episodes of coughing or sneezing or through contact with frequently 
handled infected surfaces (CDC, 2012-2013). The influenza disease is caused by a group 
of influenza viruses, Type A, B, and C (CDC, 2012-2013). Although influenza affects all 
ages, the older adults are particularly vulnerable because they often have chronic illnesses 
which put them at a greater risk for influenza complications, including pneumonia 
(Molinari, et al, 2007). Immunization against influenza viruses is considered one of the 
most important health interventions to control seasonal influenza and to prevent 
unnecessary hospitalizations and premature deaths among the older adults yet many older 
adults do not obtain the influenza vaccine (CDC, 2012). 
WHY THIS STUDY IS NEEDED 
This study is carried out in Brooklyn New York because a survey done among Brooklyn 
residents reported that influenza and pneumonia combined is the third leading cause of 
death in Brooklyn (SUNY Downstate Medical Center, 2010).  
 
How you can contribute to Decreasing Influenza Hospitalization and Death Rates 
among Older Adults? 
Take the chance today and participate in the survey to help me determining the 
relationship between perception and belief among the elderly Brooklyn residents and 
their low influenza vaccination uptake rate. The study is being conducted as part of a 
Walden University dissertation fulfillment requirement by Cheryl Hilliman. With great 
honor I am encouraging you to participate in this survey to help clinicians in developing 
appropriate interventions specific to your older adult population who is vulnerable 
influenza and its complication.  
Please call Cheryl Hilliman at (347) 675-7353 or Email me at 
Cheryl.hilliman@waldenu.edu 
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Appendix J: GPCOG Screening Test Authorization 
 
Instructions: For these questions, simply check the box that best represents your answer. 
These questions are to determine if you meet the criteria to participate in the survey 
study. 
1. Are you a member of this senior citizen center? 
• Yes 
• No 
2. Are you read and write English?  
• Yes 
• No 
3. Can you can you independently make appropriate decisions.  
• Yes 
• No 
4. Do you live in Brooklyn? 
• Yes 
• No 
5. Are you willing to participate in a 4 to 5 minutes screening to evaluate your 
current cognitive status? 
• Yes 
• No 
If you have answered yes to all the questions and you are willing to take the 
screening to test your cognitive ability, please put your initials of first and last 
names on the area provided below. 
First and Last Name Initials _____  
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Appendix K: GPCOG Screening Test 
 
Participant Initials: __________________________ Date: _____________ 
 
Items Correct Incorrect 
1: Name and Address for Subsequent Recall Test 
Read the following to the patient: 
I am going to give you a name and address. After I have said it, I 
want you to repeat it. You must remember this name and address 
because I am going to ask you to tell it to me it again in a few 
minutes: Mary Jones, 342 East 83rd Street, Brooklyn.  (Allow a 
maximum of 4 attempts). 
    
2. Time/Orientation 
  What is the date? (exact only)                        
  
    
3. Clock Drawing – use blank page 
Please mark in all the numbers to indicate the hours of a clock      
4. Please mark in hands to show 10 minutes past twelve o’clock          
  (12:00) 
    
5.  Information 
Can you tell me something that happened in the news recently? 
(Recently = in the last week. If a general answer is given, e.g. "war", 
"lot of rain", ask for details. Only specific answer scores) 
    
Recall 
What was the name and address I asked you to remember? 
Top of Form 
 Mary   
 Jones   
342   
East 83rd Street   
Brooklyn   
 
    
 
To get a total score, add the number of items answered correctly 
Total correct (score out of 9) 
1. If patient scores 9, no significant cognitive impairment and further testing not 
necessary. 
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2. If patient scores 5-8, more information required. Proceed with Step 2, informant 
section. 
3. If patient scores 0-4, cognitive impairment is indicated. Conduct standard 
investigations. 
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Informant Interview 
 
Date: ____________ Informant’s name: ________________________ 
 
Informant’s relationship to patient, i.e. informant is the patient’s: ___________________ 
These six questions ask how the patient is compared to when s/he was well, say 5 – 10 
years ago.  
 
Compared to a few years ago: you will choose any of the following answers 
 
Don’t know _______   Yes _______ No __________ N/A ________ 
 
1. Does the patient have more trouble remembering things that have happened 
recently than s/he used to? 
Don’t know _______   Yes _______ No __________ N/A ________ 
 
2. Does he or she have more trouble recalling conversations a few days later? 
Don’t know _______   Yes _______ No __________ N/A ________ 
 
3. When speaking, does the patient have more difficulty in finding the right word or 
tend to use the wrong words more often? 
Don’t know _______   Yes _______ No __________ N/A ________ 
 
4. Is the patient less able to manage money and financial affairs (e.g. paying bills, 
budgeting)? 
Don’t know _______   Yes _______ No __________ N/A ________ 
 
5. Is the patient less able to manage his or her medication independently? 
Don’t know _______   Yes _______ No __________ N/A ________ 
 
6. Does the patient need more assistance with transport (either private or public)? 
Don’t know _______   Yes _______ No __________ N/A ________ 
 
(If the patient has difficulties due only to physical problems, e.g. bad leg, tick ‘no’) 
To get a total score, add the number of items answered ‘no’, ‘don’t know’ or ‘N/A’) 
Total score (out of 6) 
If patient scores 0-3, cognitive impairment is indicated. Conduct standard investigations. 
